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ABSTRACT
Predictive modeling of the dynamic, multivariate, non-linear, stochastic systems
of biology is a difficult enterprise. High throughput measurement techniques are
enabling new approaches to computational biology, but the small number of sam-
ples typically available relative to the number of features measured make additional
sources of information critical for accurate predictions. In this dissertation, we offer
an approach to incorporate biological pathway knowledge into a predictive stochastic
model for genetic regulatory networks. In addition, we propose a statistical model
for shotgun sequencing and use computational approximation strategies to derive
optimal estimators for classification.
We perform comparisons of classifiers trained using this framework to other ex-
isting classification rules including non-linear support vector machines. Using both
synthetic and real sequencing data, our classifiers delivered lower classification error
rates than existing classification techniques. In addition, we demonstrate using prior
knowledge to construct the classifier through properly constructed prior distributions
and several scenarios where this increases classification performance.
This research establishes a flexible framework to generate optimal estimators
with respect to statistical biological models. By demonstrating the role and power of
computation in unlocking these estimators, we point future research efforts towards
this computationally intensive approach for the computational biology field.
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1. INTRODUCTION
Biological organisms can be considered high-dimensional, non-linear, stochastic,
dynamical systems. Each of these attributes increases the difficulty of making pre-
dictions about the behavior of these complex machines. Additionally, the known
operational mechanisms of biological systems are only partially catalogued adding
another level of difficulty to the task. Despite this, disciplines ranging from medicine
to synthetic biology drive the need to develop methodologies to make accurate pre-
dictions in the face of this difficult and partially understood domain.
Recent developments in the field of high-throughput biological measurement tech-
niques – most notably shotgun sequencing – have increased our ability to probe the
internal workings of the cell. These techniques produce measurements of the entire
transcriptional profile of a cell, or sequence an entire genome. But despite rapidly
dropping costs of these techniques, the number of samples obtained is typically much
smaller than the number of features measured. This positions the analyses of these
dataset squarely in the “small sample” domain where common statistical assumptions
such as asymptotics cannot be relied upon.
Despite the difficulty of the domain and the small number of samples available,
two facets of the problem, if properly leveraged, can enable forward progress. First,
for decades biologists have worked to discover knowledge regarding the mechanistic
underpinnings of biology in the form of pathways. These pathways describe known
relationships between genes, proteins, RNAs, and other functional elements of the
cell. Secondly, with the data and pathway knowledge available, we are typically
not immediately interested in a full understanding of the biological system itself.
Instead, we would often like to make predictions about some limited aspect of the
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system. For example, medical practitioners often want answers to questions such
as, “what subtype of cancer is my patient suffering from?” and “which treatment
will lead to the best prognosis?”. Similarly biologists ask targeted questions of their
experimental datasets such as, “what mechanism is responsible for this observed
shift in phenotype?” and “which experiment should I perform next to discover this
mechanism?”
Leveraging those two insights, in this dissertation, we propose techniques to utilize
biological pathway knowledge to make predictions about biological systems.
1.1 Contributions
The contributions made in this dissertation result from two primary research
projects. First, we developed an algorithm to use biological pathways to construct
a stochastic dynamical model for gene regulatory networks. This model can then
be used for making predictions of system behavior under unobserved operating con-
ditions. We then applied this technique to build an NF-κB regulatory model using
pathways from the literature. We then used additional mouse knockout experiments
available in the literature for an external qualitative validation. Secondly, we wished
to improve this technique to develop an optimal estimation methodology for the in-
corporation of prior knowledge with high-throughput data. We achieved this in the
realm of classification using Optimal Bayesian Classification and the application of
computational approximation techniques.
1.1.1 Markov models for pathway knowledge
The cell is the essential functional unit of life, and an understanding of its internal
mechanisms has occupied a large proportion of the productive output of biology.
Biological pathways represent a formalization of much of this knowledge in the form
of mechanistic dependencies between the functional elements in a cell.
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Unfortunately, the information inherent in these pathways is incomplete and often
conflicting due to cellular context including epigenetics and internal or environmental
conditions for the cell. Additionally, the information is univariate and therefore does
not typically provide enough information alone to make accurate predictions in light
of the cellular context.
We address that problem in Section 2 by developing an algorithm which takes
as an input a set of pathways and outputs a Markov chain model of the system
which evolves consistently with the pathways. This requires a procedure to deal with
inconsistencies in the pathway information that may arise due to differing cellular
context when the pathway was originally discovered.
We then use this Markov chain to make predictions regarding the steady state
distribution of the gene/protein expression. These steady state distributions can
then be used to predict phenotypes based on known gene actions in the cell.
The NF-κB network is of prime interest in translational medicine and biology as
it acts as a hub network of the cellular inflammatory response mechanism. Chronic
inflammation is linked to many diseases such as autoimmune disorders, the progres-
sion of cancer, and heart disease. Therefore, it is of great interest in translational
medicine to produce accurate predictions about the activation of NF-κB given a set
of conditions (or treatments) surrounding the upstream signaling network.
We obtained 28 pathways from the NF-κB literature and transformed them into a
binary vector valued Markov chain model of the NF-κB network. We then compared
the predictions of this Markov chain under seven network perturbations to the litera-
ture where a seven analogous mice knockout models were performed. This qualitative
validation of the network model demonstrates that pathways can encode enough in-
formation regarding the system when intelligently combined, and the Markov chain
model maintains this information in a consistent manner enabling predictions under
3
perturbation which match biological observations under similar perturbations.
1.1.2 Optimal Bayesian classification for non-Gaussian sequencing datasets
While the approach taken in Section 2 was seen to produce acceptable predictions,
it still remains essentially heuristic. In Section 3, by adopting a cost function and an
optimization approach, we find optimal estimators for predictions of biological sys-
tems. Specifically, we consider the prediction problem of classification. In addition,
instead of considering pathway information, we utilize a new statistical model (this
time of the data generation process) in order to operate on labeled sample data and
prior distributions to train an optimal classifier.
This work builds on previous work by Dalton and Dougherty [15, 16, 17, 18]
where they discovered MMSE classifiers for Gaussian and multinomial distributions.
However, we wished to apply these methodologies to sequencing data which is a
widespread biological measurement technique and does not conform to Gaussian dis-
tributional assumptions. This required a statistical feature-label distribution with
considerably more complexity than multivariate Gaussian or multinomial distribu-
tions alone. We therefore proposed a hierarchical Poisson model to encapsulate the
known processes that sequencing data undergoes from the biology to the resulting
measurements.
Utilizing a statistical model that aligns closely with the underlying measurement
process provides several advantages over simpler phenomenological statistical models:
• Placing prior distributions over the parameters of the model is more straight-
forward as the parameters of the model relate to measurable, real world, quan-
tities.
• The inferred parameters of the model are easier to interpret and troubleshoot
should problems arise.
4
• The flexible construction of the model allows the addition or subtraction of
complexity as the data warrant (or require) it.
The downsides to these complex models is the loss of analytical tractability. We
therefore developed a computational approximation strategy to arrive at the op-
timal estimators using tools such as Markov chain Monte Carlo and Monte Carlo
integration.
We validated the performance of these models and subsequent optimal classifiers
on a variety of synthetic datasets against other classification techniques. We also used
a real dataset from The Cancer Genome Atlas to classify subtypes of lung cancer
sequencing data using the same set of available classifiers. The optimal classifier
exhibited superior performance in nearly all cases.
We also applied the same statistical model in a feature selection study to detect
groups of genes which well separate phenotypes of interest. In this capacity, we
utilized two additional optimal estimators surrounding the prediction problem: the
Bayesian error estimate, and the mean square error of the Bayesian error estimate.
These two estimates give a salient measure of the separation of the phenotypes and
a quantification of the uncertainty in that estimate.
We then applied the three estimators (including the optimal classifier itself) to
a dietary animal model dataset to discover gene pairs and triplets that were not
individually differentially expressed, but together well separated the groups with
low error estimates and low uncertainties around those estimates. This led to novel
biological insights to the system which were not available using widely available to
the differential expression analysis techniques common in sequencing data analysis.
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1.2 Organization
Section 2 introduces a novel algorithm to produce binary vector valued Markov
chain models of genetic regulatory networks consistent with biological pathway knowl-
edge. Section 3 explains an optimal estimation framework to use prior knowledge
and data for sample classification. Section 4 extends the work in Section 3 for feature
selection of sequencing datasets using an additional pair of optimal estimators. And
Section 5 concludes the dissertation with summarizing remarks and future work.
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2. FROM BIOLOGICAL PATHWAYS TO PREDICTIVE MODELS∗
2.1 Introduction
Biological regulatory network models offer the promise of one day applying sys-
tems based approaches for cancer diagnosis and therapy [27, 21]. Consequently, it
is not surprising that the systems biology literature contains many algorithms to
infer such regulatory networks from (time-course) microarray data [46, 72, 24, 1, 45].
Inferring such networks is inherently difficult because of the limited availability of
the data and the fact that most of these algorithms do not include mechanisms for
incorporating prior knowledge, which could potentially reduce the data requirement.
Consequently, most of these network models have not been validated, thereby hin-
dering their use in translational science and medicine.
Before the advent of high throughput measurement techniques such as microar-
rays and shotgun sequencing, biological experimentation often focused on uncovering
(mostly univariate) relationships between genes and proteins in the production of
what is usually referred to as pathway knowledge. This pathway knowledge is based
on empirical observations across different experiments that have acquired some degree
of validity through the peer review process. While not all pathways in the literature
are accurate, and some pathways may in fact be conflicting, we believe that they
offer an excellent foundation for the network construction process especially when
combined with high throughput data for model refinement and validation.
In the absence of any pathway knowledge, one would have to assume that each
protein behaves randomly. In other words, with no knowledge of the interactions
∗Parts of this section are reproduced with permission from Knight, J.M.; Datta, A.; Dougherty,
E.R. "Generating Stochastic Gene Regulatory Networks Consistent with Pathway Information and
Steady-State Behavior", IEEE/ACM Transactions on Computational Biology and Bioinformatics,
59(6), 1701-1710 2012. doi:10.1109/TBME.2012.2192117 Copyright© 2012 IEEE.
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between proteins we cannot predict if a certain protein will be expressed more or
less than average over the long run. With available pathway information, however,
one can refine the random model by using the knowledge to guide the behavior of
the model when the contextual information of the pathway is satisfied. By requiring
the model to obey the pathway information, we can be sure that the model reflects
the pathway knowledge that is available. By using a significant amount of pathway
information we can reduce the data requirement and generate models that produce
predictions that are more meaningful than those with little or no prior information.
Based on the preceding discussion, it is clear that the long run behavior of the
model is a function of the amount of pathway information available about the system
and the initial conditions. If we know too little about the system, then the long
run behavior will reflect the unknown, random evolution and no conclusions can be
made. However, if the long run behavior differs from the stochastic background level,
then the pathway knowledge and initial conditions are sufficient to make qualitative
predictions about that system. This is what we will be demonstrating in this section
by using a model which captures the behavior of the pathways relating to the NF-κB
system.
A few key assumptions underlie our model development. The first is the dis-
crete state and discrete time approximation of protein behavior. This is a large
assumption, but the most important one utilized in this section. It has been vali-
dated in many biological contexts [53, 22], and provides an important simplification
that enables large scale network modeling with pathway data. Indeed, as pointed
out in [63], such discrete-time discrete-state modeling avoids the need for making
continuous-time measurements of protein concentrations and facilitates the accom-
modation of genes/proteins which exhibit ON/OFF switch-like behavior. Moreover,
discrete time systems are easier to analyze, model and control in real time [60].
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The second assumption that we make is that there is no prior knowledge about the
initial state of the cell and only the presence or absence of external stimuli is known.
In other words, we assign a uniform initial distribution to all possible states and allow
the pathway constrained model to stabilize into attractor cycles. This assumption
has the effect of distributing the resulting probability mass of the cell states to the
states that are in the attractor cycles. Furthermore, these attractor cycles have a
total probability that is proportional to the size of the basin of attraction. A similar
conclusion was reached by Huang [49] but from a biological argument of cellular
homeostasis in the presence of continual perturbations of the inter and intra cellular
environments.
In this section, we propose a new method for generating networks from pathway
information. We then apply this method to the set of proteins that compose the NF-
κB regulatory network to build the transition probability matrix of a discrete-state,
discrete-time Markov chain that produces predictions that agree with the literature.
The NF-κB system was chosen due to the prevalence of associated pathway infor-
mation in the literature as well as due to its biological importance in cancer and the
innate immune system.
2.2 Obtaining the pathways
In any network inference procedure, the first step consists of selecting a specific
biological system and choosing the specific agents for inclusion in the model. In this
section, this task was performed manually, although future work could include using
selection techniques such as statistical tests on high-throughput data to identify the
most relevant molecules for state based modeling.
The model generated in this section consists of protein species with the exception
of one lipoglycan (lipopolysaccharide). In general, the species in the pathways and
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the resulting model can be a mixture of any types of biological entities as long as
the pathways are accurately reflect the relationships being studied. Throughout
this section, we will refer to the elements in the model as proteins with the tacit
understanding that sometimes other biological entities would also be admissible.
To obtain pathway data for this section, we manually reviewed the biological
literature relevant to the NF-κB system and recorded a pathway when significant
biological evidence was available and the molecules involved in the pathway were
chosen to be significant. For interactions that included non-significant species, the
pathway was either ignored or extended upstream and downstream until it included
significant species. The resulting pathways and the references used to arrive at them
are summarized in Table 2.1. A full description of the NF-κB system appears later
in section 2.6.
Here each pathway description consists of two parts, the predicate and the subject
and are separated by the implication sign, =⇒ . The information that the pathway
contains can be understood as: “when the predicate is true, the subject is implied to
occur in the future." The timing with which this dependence occurs is not known,
but in this section we assume that the dependence relationship is implemented at
the next time step as in [63].
Using the pathway data, one can determine which proteins are upstream of each
other and also determine the set of predictor proteins, i.e. the proteins whose ac-
tivity status collectively determines the time course updates of a given protein. In
the general case, it is possible that one could have this information without having
any pathway knowledge about the specific behavior of the regulation. While the
algorithm presented below can handle this case equally well, in the NF-κB model
considered here we did not have any knowledge of this type and therefore the pre-
dictor sets were derived directly from the pathway knowledge.
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Table 2.1: Pathways comprising the NF-κB system. Reproduced with permission
from [56].
Pathway Reference
RIP1 = 1 =⇒ NEMO = 1 [43]
A20 = 1 =⇒ NEMO = 0 [43]
LTβR = 1 =⇒ NEMO = 1 [43]
A20 = 1 and RIP1 = 1 =⇒ NEMO = 0 [43]
RIP1 = 0 and LTβR = 0 =⇒ NEMO = 0 [43]
TNFR = 1 =⇒ AP-1 = 1 [43]
TNFR = 0 =⇒ AP-1 = 0 [43]
TNFR = 1 =⇒ RIP1 = 1 [44]
TNFR = 0 =⇒ RIP1 = 0 [44]
LPS = 1 =⇒ TNFR = 1 [54]
TNFα = 1 =⇒ TNFR = 1 [54]
LPS = 0 and TNFα = 0 =⇒ TNFR = 0 [54]
IKKα = 1 =⇒ p52 = 1 [43]
IKKα = 0 =⇒ p52 = 0 [43]
LTβR = 1 =⇒ IKKα = 1 [43]
NEMO = 1 =⇒ IKKα = 1 [43]
NEMO = 0 and LTβR = 0 =⇒ IKKα = 0 [43]
NEMO = 1 =⇒ IKKβ = 1 [90]
LPS = 1 =⇒ IKKβ = 1 [44]
NEMO = 0 and LPS = 0 =⇒ IKKβ = 0 [90, 44]
p65 = 1 =⇒ IκB = 1 [43, 88]
p65 = 1 =⇒ A20 = 1 [43, 88]
p65 = 0 =⇒ A20 = 0 [43, 88]
IKKβ = 0 =⇒ IκB = 1 [43]
IKKβ = 1 =⇒ IκB = 1 [43]
IκB = 1 =⇒ p65 = 0 [43]
IκB = 0 =⇒ p65 = 1 [43]
IKKα = 1 =⇒ p65 = 0 [61]
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Let us now demonstrate this algorithm on a part of the NF-κB system. From
Table 2.1, we consider the pathways related to the behavior of NEMO. These are the
first five entries in that table and are given by:
RIP1 = 1 =⇒ NEMO = 1 (2.1)
A20 = 1 =⇒ NEMO = 0 (2.2)
LTβR = 1 =⇒ NEMO = 1 (2.3)
A20 = 1 and RIP1 = 1 =⇒ NEMO = 0 (2.4)
RIP1 = 0 and LTβR = 0 =⇒ NEMO = 0 (2.5)
The pathways listed above mandate the following relationships: when RIP1 is
activated, it activates NEMO; when A20 is activated, it deactivates NEMO; when
LTβR is activated, it activates NEMO; when both A20 and RIP1 are activated,
NEMO is deactivated; and when RIP1 and LTβR are both inactive, NEMO is de-
activated. From these, we can infer that a reasonable predictor set for NEMO is
{A20,LTβR,RIP1}. One can similarly arrive at predictor sets for the other biologi-
cal entities in Table 2.1.
2.3 Creating Karnaugh maps from pathways
Having identified the predictor set for each protein, we can use a Karnaugh map
[52] to determine the update rule for that protein. The method used is an extension
of the one developed in [63]. For each protein, using its predictor set, we initialize
a Karnaugh map with every entry in the map containing the unknown ‘x’. This is
consistent with the observation that to start with we have no information about how
the current value of the prediction proteins affects the update value of the predicted
12
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Figure 2.1: The process of developing the Karnaugh map using the pathways asso-
ciated with NEMO. For each step in the process, we evaluate each pathway in turn.
In each pathway, the predicate specifies certain locations in the Karnaugh map and
these are shaded in yellow in the corresponding table. Reproduced with permission
from [56].
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protein at the next time step. The Karnaugh map entries can then be updated by
incorporating the pathway information. For instance, consider the update of NEMO.
The initial blank Karnaugh map for it is shown in Fig. 2.1A. We will refer to the
locations in the Karnaugh map using the vector [A20, LTβR, RIP1]. Thus 000 would
correspond to the square in the upper left corner of the map and so on. Now, using
the first pathway: RIP1 = 1 =⇒ NEMO = 1, we can fill all the entries that
correspond to RIP1=1 with ones, and this results in the Karnaugh map shown in
Fig. 2.1B.
We next proceed to fill the locations 100 and 110 with zeros to satisfy the re-
quirements of the second pathway: A20 = 1 =⇒ NEMO = 0, but are faced with a
conflict when RIP1=1 and A20=1. At the two conflicting locations we replace the
ones with c1. The letter c indicates a conflict while the superscript 1 indicates that
the conflict comes from pathways which contain only one protein in the predicate.
The reasoning for this notation will become clear later in this section. This results
in the table in Fig. 2.1C.
We next consider pathway three: LTβR = 1 =⇒ NEMO = 1, which mandates
that the ’x’ at location 010 be replaced by a 1. Since location 110 contains a 0, so we
replace it with a c1 to indicate that there is a conflict. Finally, location 111 already
has a c1 and because this pathway only contains one protein in its predicate, we must
leave the c1 in place. This leads to the table shown in Fig. 2.1D.
Next we look at the fourth pathway: A20 = 1 and RIP1 = 1 =⇒ NEMO = 0.
The predicate here applies to locations 101 and 111. Both of these contain c1 conflicts,
but because this pathway contains two proteins in its predicate, we acknowledge
this pathway has more specific information regarding this particular experimental
scenario and can override the c1 conflicts. Therefore we fill the locations 101 and 111
with zeroes and obtain the table shown in Fig. 2.1E.
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For the final pathway: RIP1 = 0 and LTβR = 0 =⇒ NEMO = 0, the predicate
applies to the locations 000 and 100. The former has an x, so we replace it with a 0,
and the latter is already a 0. Therefore we are now finished with NEMO’s pathway
information and are left with the Karnaugh map of Fig. 2.1F. In this map, we see
there is only one uncertainty condition at the location 110.
The procedure demonstrated on the NEMO example above can be generalized by
proceeding through the pathways in order from the least specific predicates to the
most specific ones and filling in the Karnaugh map entries if information is available
or invalidating information already provided if there are conflicts in the pathway
information. This general procedure is presented in Algorithm 1. The key difference
between the algorithm presented in [63] and the one presented here is that in [63], one
attempts to resolve the conflicting entries in the Karnaugh maps by suitably altering
the timings of some of the pathways whereas here the conflicts in the Karnaugh
maps are retained. Consequently, the state transitions following a conflict will not
be unique and by assuming that all the subsequent states are equiprobable, we can
come up with probabilistic state transition graphs which are introduced next.
2.4 Probabilistic state transition graphs
The Karnaugh maps generated using the procedure of the last section can be used
to produce the probabilistic state transition graph (PSTG) of the system. A PSTG
is a directed graph that describes the evolution of the biological system through
time. It consists of kn nodes that correspond to the states of the system where k is
the number of quantization levels associated with the activity state of each protein
(assumed throughout the rest of this section to be two for a binary discretization)
and n is the number of proteins in the system. Additionally, each directed edge
indicates a viable transition between states as allowed by the pathway information.
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Figure 2.2: A simplified PSTG for the NEMO protein with predictors that are all
static for the purposes of illustration. Here the binary value of the state should
be interpreted as [A20, LTβR, RIP1, NEMO]. The red, dashed edges represent one
possible configuration of the network, while the blue, dotted edges represent the
other configuration. Reproduced with permission from [56].
For example, using the NEMO pathways and the Karnaugh map generated in
the last section we obtain a simplified but illustrative example of a PSTG for this
system as shown in Fig. 2.2. We assume here that the predictor proteins have no
predictors themselves and therefore exhibit static behavior. This is seen in Fig. 2.2
where the edges of the PSTG, or the allowed transitions, are between states with
identical values for the predictor proteins and only differing in the values of NEMO.
Also, based on the Karnaugh map generated from the NEMO pathways, we expect
uncertainty at the state 110x and indeed, both the states 1100 and 1101 have two
outgoing edges each. One of these creates a self loop, and the other directs to the
corresponding state with the value of NEMO flipped.
The PSTG is actually a compact representation for the class of networks which the
uncertain Karnaugh maps such as the one in Fig. 2.1F generate. To use the example
above, we could also represent the uncertainty of NEMO at 110x by creating two
separate networks with two corresponding state transition diagrams. One network
would contain the blue, dotted edges in Fig. 2.2 and predict that NEMO should
equal 0 when A20=1, LTβR=1, and RIP1=0, while the other would have the red,
dashed edges and predict that NEMO should equal one for the same set of predictor
values.
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Figure 2.3: A synthetic example of the complete process from pathways to long run
probabilities. (A) Pathways for the three proteins: protein A has no predictors, B is
predicted by A, and C is predicted by A and C. (B) The resulting Karnaugh maps
with one final conflict obtained using the method described in Algorithm 1. (C)
The resulting PSTG shows two separate basins. The left basin has a single attractor
state 001 while the right basin has two states in the attractor, 111 and 110. (D-F)
The probability mass in each state at the (D) initial stage (E) after the first state
transition, and (F) after many state transitions have taken place. (G) The resulting
protein B knockout (B= 0) PSTG. The state space is halved as the states with B=1
are no longer considered in the possible transitions. Reproduced with permission
from [56].
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Let us now demonstrate the process of converting Karnaugh maps to PSTGs.
We will use the synthetic example in Fig. 2.3A where we are given five pathways for
the three proteins A, B, and C. These produce the two Karnaugh maps in Fig. 2.3B
and the resulting PSTG is shown in Fig. 2.3C. As can be seen, protein A has no
predictors and thus the state space can be partitioned into two basins according to
its activity.
To produce the PSTG in Fig. 2.3C, we begin by listing all the possible 23 states
as unconnected nodes in a graph. Then, for each node we use the Karnaugh maps to
update the status of each gene and then concatenate this information to determine
the next state to which the model will transition to. For example, for the state
000, protein A has no predictors and therefore no Karnaugh map so we assume
it remains in the state 0. Using protein B’s Karnaugh map, A is currently 0, so
Bnext = 0. Finally, proteins A and B being zero imply Cnext = 1. Combining all this
information creates a transition edge from state 000 to 001 in the PSTG.
As another example, consider the state 111. Following the above logic, Anext = 1
and Bnext = 1 but Cnext is a conflict, so 111 will progress to 11x which can be
expanded to 110 and 111. This is shown in Fig. 2.3C, where the node 111 has two
outgoing edges, a self loop and an edge linking to 110.
The PSTG, as in Fig. 2.3C, can also be interpreted as the state transition graph
of a Markov chain. Thus, the Karnaugh maps can be converted into a 2n × 2n
(n = 3 here) transition probability matrix where each entry [pi,j]2n×2n represents the
probability of the model transitioning from state i to state j in one time step. This
matrix is stochastic, and is a row normalized sum of the individual deterministic
state transition matrices of the resulting class of Boolean networks that would be
required to accommodate the uncertainties associated with the different Karnaugh
maps. The PSTG is a compact, sparse representation of this transition probability
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matrix, and this is what motivates us to use this framework to simulate the long run
behavior of the model.
2.5 Simulating long run behavior
A chief objective of the developed model is to obtain some useful measure of the
long run behavior of the system akin to the steady state distribution for an ergodic
Markov chain. Unfortunately, the PSTG generated using the above method does
not necessarily provide an irreducible or aperiodic state space. Therefore, we must
approximate its long run behavior as explained in the following subsections.
2.5.1 A synthetic example
For illustrative purposes we start with the synthetic example in Fig. 2.3. Since
we do not have any prior knowledge as to whether a given cell exhibits activated
protein A, we make no assumptions about the cell initially being in either basin. In
general this would apply to all the proteins in our model and ,therefore, we initialize
the states in our network with uniform initial probabilities of 0.125 each as shown in
Fig. 2.3D.
We can think of this initial probability as our initial belief of the state of the
system. Then the algorithm can be understood as an application of the knowledge
incorporated in our model to refine the initial belief. We will refer to this belief as
the probability mass.
For transitions between states we again utilize uniformity by assuming that the
transition probability from one state to the chronologically next one is equal to the
inverse of the outgoing degree from the state of origin. So for a state with two
outgoing edges such as 110 in Fig. 2.3C, the probability to transition to any of its
children (110 and 111) will be 0.5.
Now our model dictates the evolution of the states, so any cell in state 010 will
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progress in one time step to state 000, so we can move the probability mass in state
010 to state 000. The same applies to state 011 as its mass will “flow" to state 000.
Now, state 110 has two outgoing edges, so our model is ambiguous about whether a
cell in state 110 will stay in state 110 or if it will transition to 111. Therefore, we
split the probability mass in state 110 and place half of it in state 110 and half in
state 111 for the next time step. The result of the first run of the process is seen in
Fig. 2.3E.
Through iteration of this process, the probability in each transient state tends
towards 0.0. This can be seen in the example as after the first step of the algorithm,
the states along the top are transient because once we leave them, we never return.
This is clear from Fig. 2.3E where the probability mass has already been depleted
from these transient states and will remain at 0.0 for the remaining lifetime of the
model under these conditions. At the next stage, we arrive at Fig. 2.3F, from which
we can see that after the second iteration of the algorithm, state 000 has no remaining
probability mass and will remain that way for the remaining simulation because the
state is transient and has no return path.
In simple attractor cycles such as the one consisting of the nodes 111 and 110 or
singleton attractors such as 001 in Fig. 2.3F, we can calculate the long run probability
mass intuitively. The resulting mass in a singleton attractor is obtained by summing
all the initial masses in its basin of attraction. For simple attractor cycles, we can
sum all of the initial mass in the basin of attraction for that cycle and divide it by
the number of nodes in the cycle. In this way, we can get an approximation about
how often we could expect the biological system to exist in certain states.
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2.5.2 The general method
The intuitive reasoning described above where we iterate over the nodes and
add their masses to the downstream nodes applies when the PSTG is acyclic and a
preorder traversal through the graph exists. However, with the possibility of cycles,
no such preorder traversal must exist and we are forced to introduce an accumulation
buffer to describe a general algorithm that works with cycles for any node traversal
order.
Let each node have a probability mass and an accumulation buffer. For each
node we first initialize the mass of each node to be uniformly distributed over the
entire graph, and set the accumulation buffer to zero. Then for each node divide
its current probability mass by the number of its outgoing edges and then add that
amount to the temporary accumulation buffers for each of its child nodes. Then for
each node, set the probability mass to be the value in its accumulation buffer and
reset the accumulation buffer to zero.
Repeating this algorithm will result in the probability mass accumulating in the
attractors of the system. In the case of aperiodic attractors, the masses will converge
to a limiting probability mass, but we must be careful about handling the possibility
of periodic attractors. Repeatedly using the algorithm in this case might result in
the propagation of an unbalanced mass around the cycle, analogous to oscillatory
behavior in undamped systems. To overcome this problem, it is necessary to first
run the algorithm a sufficient number of times to eliminate all the transient states
and then go through several runs of the algorithm and the final probability mass
in the attractor cycle states can then be taken to be an average of the probability
masses from the final runs. This essentially smoothens out any oscillations in the
probability mass distribution in the attractor cycles.
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2.5.3 The steady state activity vector
Now, from a biological point of view, it is more relevant to determine how often
a particular protein is active instead of determining how much time is spent in a
particular state. Accordingly, we apply a transformation to the long run probability
approximation, and define a steady state activity (SSA) vector with n components,
indexed by 0 to n− 1, corresponding to the n proteins in the model. The i-th com-
ponent of the SSA vector, characterizing the activity of the i-th protein, is computed
as:
SSA(i) =
2n−1∑
j=0
PA(j)zi(j)
where zi(j) is the binary value of the i-th protein in the j-th decimal state, and
PA(j) is the j-th entry of the Probability Approximation vector resulting from the
algorithm presented in the previous subsection. The resulting SSA(i) takes values
in the interval [0, 1] according to the probability that the model is likely to exist in
states where protein i is active. For example, an SSA(i) value of 1 indicates that the
i-th protein is active in every attractor state.
Applying this to our example, in Fig. 2.3F, the SSA for protein A, i.e. SSA(0), is
calculated by considering the two attractor states 111 and 110 with active protein A
as shown in the right hand basin in the figure. Therefore, SSA(0) = 0.25+0.25 = 0.5.
Similarly, SSA(1) (B) is also 0.5 while SSA(2) (C) is 0.75, the latter being due to the
fact that all attractors have protein C active except the state 110 which has a final
mass of 0.25.
We next further justify the need for using the SSA vector instead of the state
vector. Consider the network that we have constructed by applying Algorithm 1 to
the set of 28 pathways involving NF-κB. With the external stimuli set to TNFα = 1,
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Figure 2.4: The resulting communicating class of states for the full NF-κB PSTG
when the stimuli conditions are set to TNF=1, LPS=0, and LTβR=0. The thirteen
bit binary vector can be read as [A20, AP-1, IκB, IKKα, IKKβ, LPS, LTβR, NEMO,
p52, p65, RIP1, TNFα, TNFR]. To give a walk through of one state transition,
starting at the upper right state, 0100000010111, many things occur in one transition:
IκB is inactive and thus at the next state p65 translocates to the nucleus to become
active; NEMO is activated by RIP1; p52 is deactivated as IKKα is not activating
it; and IκB becomes active, as constitutive expression allows it to repopulate the
cytoplasm in the absence of activated IKKβ. All of these changes results in the
model evolving to state 0110000101111. Reproduced with permission from [56].
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LPS= 0, and LTβR= 0, the only communicating set of states for the resulting PSTG
is displayed in Fig. 2.4. Due to the size and complexity of the resulting set of states, it
would be difficult, if not impossible, to compare the behavior of this PSTG with that
obtained from any of the knockout experiments. The concept of the SSA vector was
introduced precisely to ameliorate this problem and aids in carrying out qualitative
comparisons with the experimental data. This will be demonstrated in the next
section.
2.6 The NF-κB system
Nuclear factor-κB (NF-κB) is a protein dimer from the rel family of transcription
factors that promote the expression of over 100 genes, primarily in the immune system
[37]. The NF-κB system’s primary role in the immune system is in the production
of inflammatory cytokines, small signaling proteins used extensively in cell to cell
communication. NF-κB also has both proapoptotic and antiapoptotic effects on the
cell and the balance of these responses can be adjusted by the stimulus context.
The NF-κB transcription factor is a key element in the inflammation stress re-
sponse pathway. The general architecture of this system is typical of several stress
response pathways [84]. The transcription factor NF-κB is sequestered in the cytosol
by the “sensor" which in this case is IκB and when degraded by the “transducer"
of IKKβ, it allows for a rapid downstream response without the lag associated with
de novo protein synthesis. As discussed in [84], this combination of a transducer,
sensor, and transcription factor is a common motif seen in stress response pathways
and forms the backbone of the NF-κB system.
The mammalian NF-κB family consists of p65 (RelA), RelB, c-Rel, NF-κB1
(p52/p100), and NF-κB2 (p50/p105). NF-κB is constitutively expressed, but se-
questered in the cytosol by a family of IκB inhibitor proteins which include the p100
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Figure 2.5: The pathway structure of the NF-κB system. Blue proteins are those
that are knocked out in the validation portion of this section. The presence of a
directed edge indicates that a pathway exists that shows the upstream protein causes
a change in the activity of the downstream protein. Inhibitory pathways are marked
red and terminated with a filled dot. One thing to note here is that the LPS induced
autocrine production of TNFα would seemingly imply that an excitatory connection
should be made between LPS and TNFα. However, because we want to exogenously
control TNFα, LPS, and LTβR in our knockout simulations, we consider TNFα to
be an exogenous stimulus, thereby allowing us to control that level in simulations
without affecting the autocrine feedback loop of LPS. The second thing to note is
the dotted connection from LTβR to NEMO which indicates this is a pathway with
unknown mechanism but described in [43]. Reproduced with permission from [56].
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and p105 precursors to p52 and p50, respectively, along with IκBα, IκBβ, IκB,
IκBγ, and BCL-3 [43]. These IκBs prevent the NF-κB dimers from reaching their
binding sites in the nucleus.
The IκB kinase complex (IKK) consists of the IKKα, IKKβ, and IKKγ (NEMO)
subunits. The NEMO (NF-κB essential modulator) subunit is a regulator and main-
tains the IKKα and IKKβ subunits in inactive states.
The signaling pathways involved in the NF-κB system are shown in Fig. 2.5.
NF-κB activation is generally considered to occur through two separate cascade
pathways. The canonical pathway is primarily activated by the proinflammatory
cytokine Tumor Necrosis Factor-α (TNFα). When TNFα binds to TNF receptor
protein (TNFR), it begins a signaling cascade that through the receptor interacting
protein 1 (RIP1) activates the NEMO subunit of IKK which activates both the
IKKα and IKKβ subunits [81]. The IKKβ subunit then proceeds to phosphorylate
IκB proteins which leads to their destruction through polyubiquitination and allows
NF-κB dimers, primarily p65 heterodimers and homodimers to translocate to the
nucleus and bind to promoter regions [43].
Bacterial lipopolysaccharide (LPS) is a component of bacterial cell walls that
provides an activating stimulus for Toll-like receptors 2 and 4 (TLR2 and TLR4).
These receptors also activate the canonical pathway but through MyD88 and Trif
intermediary proteins [11] that directly activate the IKKβ subunit without activating
NEMO [81]. Also, the LPS dependent pathway indirectly activates the canonical
pathway through autocrine stimulation through the production of TNFα.
The alternative pathway is activated through CD40 and LTβR and through the
NIK protein directly activates the IKKα subunit which through phosphorylation,
processes p100 into p52 which activates the nuclear localization segment (NLS) which
allows the p52 dimer to translocate into the nucleus. The alternative pathway also
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activates the canonical pathway through an unknown mechanism [43].
NF-κB activates two genes in particular that produce IκB and A20. Both of
these act as negative feedback to dampen the response of the canonical pathway.
A20 binds to NEMO and impairs the activation of the IKKβ and IKKα subunits by
RIP1 [90]. Additionally, NF-κB activates antiapoptotic genes such as cFLIP (not
shown in Fig. 2.5) that counteracts the TNFα induced activation of the proapoptotic
AP-1 family such as c-Jun [76]. Consequently, NF-κB knockouts are likely to exhibit
apoptotic behavior when subjected to TNFα stimulation. This will be borne out by
some of the knockout studies considered later in the next section.
2.7 Towards model validation using knockout studies
The model developed by us in this section was designed to preserve the biological
state transitions and stable state attractor cycles. Accordingly, it seems reasonable to
validate our model using the experimentally observed long run behavior of biological
systems. We will specifically focus on animal knockout models. This kind of model
validation is appropriate given that a long term goal of our research is to enhance
medical treatment in patients. Currently, treatment is provided through therapeutic
drugs which have physiological effects on the order of 8 to 24 hours which can be
considered to be long run behavior in the context of regulatory networks. Thus,
long run behavior would be particularly appropriate for predicting drug effects and
patient outcomes.
Biologists use knockout models to disable a specific gene or a set of genes in
a model animal and then observe the resulting physiology to determine protein
functions and interactions. Our stochastic state models also provide us a platform
with which we can replicate these experiments and examine the resulting steady
states. Comparison of the proteins’ known functions and physiological phenotypes,
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the resulting increases or decreases in prevalence, and the recorded physiology of
the real knockout experiment together provide us with a mechanism for validating
our stochastic state space model. For instance, consider the knockout experiment in
Fig. 2.3G. Here we have knocked out protein B. This results in a PSTG where all
states with protein B active are no longer considered valid and the resulting model
has a PSTG consisting only of states with inactive protein B. This results in two
attractor states, one for each original basin.
The PSTG resulting from the 28 NF-κB pathways in Table 2.1 was too large to be
visually interpreted, although for illustrative purposes a small subset of it is included
in Fig. 2.4. We compared the behavior of our model in a steady state fashion with
the phenotypes and measured protein quantities as found in the knockout studies.
Due to the qualitative nature of the data collected in the knockout experimental
studies used, the comparisons between the model and the study will by necessity
be qualitative. We believe that this still allows for satisfactory validation given
the complexity of the model, the inherently noisy nature of biological systems and
experimentation, and the large number of knockout studies examined.
2.7.1 A20−/−
Werner et al. [88] aimed to derive ordinary differential equation (ODE) models
of NF-κB regulation in response to TNFα and LPS stimulation. One of their model
parameters includes the negative feedback of A20, and to justify this, they compared
A20+/+ against A20−/− Murine 3T3 immortalized fibroblasts and measured IKK and
NF-κB activity in response to 45 minutes of TNFα stimulation. It is clear in this
comparison that the A20−/− activity of IKK and NF-κB is much higher than that
of the A20+/+ cells. This is consistent with Table 2.2(a) produced by simulating our
model where the levels of IKKα and p65 both increase when the model is constrained
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Table 2.2: Knockout studies and simulations. Reproduced with permission from [56].
Knockout
Species
Baseline Conditions Baseline
SSA
KO SSA Reference
TNF LPS
(a) A20−/− 1 0 p65=0.389,
p52=0.611,
IKKα=0.611
p65=0.400,
p52=1.00,
IKKα=1.00
[88]
(b)
IKKβ−/−
1 0 p65=0.389,
IκB=0.487,
AP-1=1.00
p65=0.00,
IκB=1.00,
AP-1=1.00
[65]
(c)
IKKβ−/−,
TNFR−/−
1 0 p65=0.389,
AP-1=1.00
p65=0.00,
AP-1=0.00
[65]
(d) p65−/− 1 0 p65=0.389,
AP-1=1.00
p65=0.00,
AP-1=1.00
[35, 76]
(e)
IKKα−/−
0 1 p65=0.600,
A20=0.600,
IκB=0.300
p65=0.667,
A20=0.667,
IκB=0.333
[66, 61]
(f)
IKKβ−/−
0 1 p65=0.60,
AP-1=1.00
p65=0.00,
AP-1=1.00
[35, 75]
(g)
NEMO−/−
(macrophage)
0 1 p65=0.60,
AP-1=1.00
p65=0.67,
AP-1=1.00
[55]
(h)
NEMO−/−
(general)
0 1 p65=0.67,
AP-1=1.00
p65=0.67,
AP-1=1.00
[55]
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to A20−/−. While the increase in p65 is small, the direction of the change is consistent
with the findings of Werner et al.
2.7.2 IKKβ−/− and TNFR−/−
Li et al. [65] used IKKβ−/− knockout mice to investigate the role of IKKβ in
the NF-κB signaling pathway. They determined that the lack of IKKβ increased
hepatocyte death due to TNFα (TNFα toxicity). This was caused by a reduction
in the amount of phosphorylated IκB and a corresponding decrease in the activation
of NF-κB which is anti-apoptotic. They also found that the IKKβ−/− knockout
did not affect c-Jun levels, a member of the proapoptotic AP-1 family which helps
explain the increased toxicity. They also measured an increase in stability in IκB
from IKKβ−/− lines, which is seen in our model as an increase in the activity of IκB
in Table 2.2(b).
They also determined that a IKKβ−/−, TNFR−/− double knockout where both
of these genes were knocked out simultaneously allowed the mice to survive to term
(rescuing the phenotype). We mirrored this same result in our model as the IKKβ−/−,
TNFR−/− double knockout in Table 2.2(c) shows the same reduction of p65 as the
single knockout, but the c-Jun (AP-1 family) activation is also reduced which reduces
the pro-apoptotic nature of the TNFα stimulus under IKKβ−/− knockout conditions.
This explains the reduction in TNFα toxicity.
2.7.3 p65−/−
Prendes et al. [76] used fetal liver hematopoietic precursors from mice embryos
deficient in RelA (p65) to study the effect of RelA deficiency in lymphocytes. They
found that the loss of RelA increased TNFα toxicity greatly which was ameliorated
when cells were induced by virus to produce the antiapoptotic NF-κB target gene
cFLIP. This indicates that the increased cell death was due to the inhibition of NF-
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κB and this is backed by our knockout model by a reduction in RelA at steady state
in Table 2.2(d).
2.7.4 IKKα−/−
Li et al. [66] used embryonic liver-derived macrophages (ELDM) from IKKα−/−
mice to determine the role of IKKα in the innate immune system’s inflammation
response. IKKα−/− ELDM cells were found to exhibit higher than normal antigen
presenting response and higher NF-κB levels in response to LPS stimulation. In
addition, Lawrence et al. [61] used a model with an inactivatable variant of IKKα
(denoted by IKKαA/A) and observed an increase in NF-κB and A20 upon the appli-
cation of LPS, both of which match our model in Table 2.2(e).
Li et al. found a decrease in the post-induction response of IκB in their IKKα−/−
cells whereas Lawrence et al. measured an increase in the amount of IκB for their
IKKαA/A macrophages. Li et al. put forth a possible explanation for this discrepancy:
in IKKα−/− knockouts, the absent IKKα proteins are no longer competing with
IKKβ for NEMO binding locations allowing more IKKβ to homodimerize under
NEMO [44]. This in turn results in more effective IκB kinase activity and thus less
IκB than the IKKα-IKKβ-NEMO complexes that exists in IKKαA/A mutants and
normal cells.
Our model as presented in this section uses only two states to describe the state
of a protein. This approximation suffices when the behavior of an inactivated protein
is the same as that when that protein is absent. In this case, it is okay to associate
both the absence and inactivation of the protein into state 0. However, in the case
of IKKα, the effect of the protein’s absence is different from that of its inactivation
and thus for complete accuracy we would need an additional state to encode for this
level of detail.
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Accordingly, our model has included the pathway associated with IKKα’s inacti-
vation and therefore matches the observations of Lawrence et al’s inactivation model
because their experimental method resulted in an inactivation of IKKα rather than
its complete absence as in Li et al’s.
2.7.5 IKKβ−/−
Park et al. [75] used fetal liver derived macrophages (FLDM) deficient in IKKβ to
investigate the mechanism of macrophage survival under stimulus to TLR4 receptors.
Some bacterial toxins such as Salmonella AvrA inhibit NF-κB while stimulating
the TLR4 receptor which was observed to result in the stimulation of macrophage
apoptosis. This is mirrored in our model in Table 2.2(f) where we see that p65 activity
drops while the AP-1 proapoptotic family remains activated. This observation is
along the same lines as that in Table 2.2(b) where, in addition, we also tracked
alterations in IκB activity under different exogenous stimuli conditions.
2.7.6 NEMO−/−
Kim et al. [55] analyzed NEMO−/− Murine B cells. Because these mice die early
in embryogenesis, they used an in vitro differentiation process to convert embryonic
stem cells to B cells. They found that NEMO is not required for B cell development,
but does affect its survival. Specifically, after an application of LPS for three days
(+LPS) or mock stimulation for the control (-LPS), the wild-type B cells maintained
population levels while the +LPS NEMO-deficient group declined in population.
Oddly enough however, the -LPS NEMO-deficient cell group also declined in similar
proportions which confounds the simple explanation of NF-κB stimulation from LPS
increasing the cell apoptosis rate.
In our model, we see in Table 2.2(g) that our NEMO−/− simulation actually shows
an increase in p65 NF-κB activation levels with a constant AP-1 level which would
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seem to indicate an increase in cell survival. This conflicts with the finding in Kim et
al. but looking more closely at the pathways, we see that the IKKα = 1 =⇒ p65 = 0
pathway in table 2.1 is from [61] where the inhibition of p65 from IKKα is seen in
macrophages. It is entirely possible that this pathway is different in developed B
cells and indeed, if we remove this pathway from the model we see in Table 2.2(h)
that the p65 levels are unchanged in the NEMO-deficient model which means the
model does not contain enough information to predict any change in behavior for
this knockout configuration.
This reinforces a key assumption made in the model derived in this section.
The model is only as accurate as the pathway data used in its generation, and for
biological regulatory systems it is often acceptable to use pathways from different
cell types and contexts. However, to achieve maximum model fidelity and prediction,
it is necessary to obtain pathways from the same cell types that we wish to make
predictions about.
2.8 Conclusions
In this section we have presented a method to produce a regulatory network
model using only minimal assumptions of predictor proteins and utilizing literature
backed pathway information. The resulting networks assume no data other than that
given and were validated using a number of biological knockout experiments from
the literature that gave matching results. The use of minimal modeling assumptions,
along with the use of literature backed information result in a model that is built on
a solid foundation of biological experimentation, and will allow for further validation
and refinement through comparison with high-throughput data and new pathway
data as they become available.
We believe that techniques such as these will play a critical role in future drug
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discovery and predicting the effects of potential drugs. The linear and intuitive nature
of (marginal) biological pathways does not completely capture the (multivariate)
complex network level behaviors of reality. However, the methods presented here
will allow for these pathways to be used as a whole to describe the possible network
behaviors in a way that could some day guide physician therapy and drug design.
To extend this work, we will next develop new techniques to leverage the data
derived from high-throughput experiments to refine these pathway derived models.
This will allow for networks that merge the two greatest sources of biological knowl-
edge, the new and the old, into models with better predictive power. Additionally, it
will be done in a minimal assumption environment that can be extended and refined
as new pathways are developed and validated.
Some pathways, such as the phosphorylation of IκB by IKKα and IKKβ could
not be represented in our modeling with one hundred percent accuracy due to quan-
tization errors in our binary discretization. In reality, both IKKβ and IKKα phos-
phorylate and deactivate IκB but IKKβ deactivates IκB at a much greater rate than
IKKα. Unfortunately, the binary quantization does not allow this information to be
retained accurately and in this model we decided to ignore the direct effect of IKKα
on IκB. Such a decision could be justified based on the wide difference in the mag-
nitudes of the effects of IKKβ and IKKα on IκB. In the future, however, we would
like to use finer quantization levels for important and well understood components
of the regulatory system to enable a model that more closely reflects reality without
greatly increasing the knowledge requirements or uncertainty.
In this section, we have ignored the fact that many species in the model such
as AP-1 and IκB are actually dimerizing families of proteins, and the specific pro-
portions of these dimers could be important to determining the resulting cellular
response. The naive approach of simply accounting for each possible combination
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of dimers would result in a huge increase in uncertainty in the model and future
work should focus on more sophisticated ways to handle this real-world biological
complexity.
In the next section, we consider an improvement to this heuristic algorithm de-
veloped here. Briefly, by starting with an appropriate estimation problem and cost
criterion we can produce optimal estimators relative to the modeling assumptions
and cost criterion.
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Algorithm 1: ProduceKMapForProtein(P,x)
/* P is the sorted list of pathway segments as described in [63]
in ascending number of predictive proteins. */
/* x is the name of the specific protein that we want to produce
a Karnaugh map for. */
/* This algorithm is simple and optimized for clarity of
exposition rather than runtime. Therefore, we use two loops
through the pathways. The first is to collect the set of
predictor proteins for this protein, and the second is to fill
in the entries of the Karnaugh map. */
foreach p ← P do
// Get the subjects S of this pathway
S ← Subjects(p);
if x ∈ S then
// Add the proteins from this pathway’s predicate
// to the set of predictors:
PredictorSet ← PredictorSet ∪ PredicateProteins(p);
initialize the Karnaugh map K[] with x’s in each location;
foreach p ← P do
// Decompose the pathway into its constituent parts
S ← Subjects(p);
if x ∈ S then
n← |PredicateProteins(p)|;
C ← PredicateCondition(p);
v ← NextStateValue(p);
// Now iterate over the locations in the Karnaugh map
foreach permutation e of the values of the PredictorSet do
/* If the permutation e matches the condition of the
predicate for this pathway, and if this pathway can
override the information already in the Karnaugh map
(i.e. it is more specific than it with n < z), then
overwrite it with the next state value subscripted
with the specificity of this pathway. Otherwise mark
the location as a conflict with this pathways
specificity of n. */
// for all z < n and y ∈ {0, 1}
if C ⊂ e and (K[e] = cz or K[e] = x or K[e] = yz) then
K[e] ← vn;
else
K[e] ← cn;
// K[] is the resulting Karnaugh map
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3. MCMC IMPLEMENTATION OF THE OPTIMAL BAYESIAN CLASSIFIER
FOR NON-GAUSSIAN MODELS: MODEL-BASED RNA-SEQ
CLASSIFICATION∗
3.1 Background
The possibility of genomic phenotype classification arose with the inception of
gene-expression microarrays. From the outset, two fundamental problems have frus-
trated the endeavor: (1) the inaccuracy of microarray measurements, and (2) small
samples. Our particular application of interest is classification using RNA-Seq data.
Modern RNA-Seq technologies sequence small RNA fragments (mRNA) to measure
gene expression, where the number of reads mapped to a gene on the reference
genome defines the count data. Given that RNA-Seq data has advantages over
microarray data, in particular, more accurate measurement, we still confront the
second fundamental problem, which is statistical, not technological: small samples
cause re-sampling-based classifier error estimators to be very inaccurate due to ex-
cessive variance and lack of regression with the true error [7, 41, 39, 40]. Since the
error rate of a classifier quantifies its predictive accuracy, it is the salient epistemo-
logical attribute of any classifier. The inability to satisfactorily estimate the error
with model-free methods with small samples implies that genomic classifier error
estimation is virtually impossible without the use of prior information, so that the
whole small-sample classification problem becomes unapproachable in a model-free
framework [29].
∗Parts of this section are reproduced with permission (CC by 4.0) from Knight, J.M.; Ivanov,
I.; Dougherty, E.R. "MCMC implementation of the optimal Bayesian classifier for non-Gaussian
models: model-based RNA-Seq classification", BMC Bioinformatics Page 401. Volume: 15, Issue:
1, 2014 doi:10.1186/s12859-014-0401-3 Copyright © 2014 Knight et al.; licensee BioMed Central
Ltd.
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The situation has been addressed by utilizing prior knowledge via a Bayesian
approach that considers a prior distribution on an uncertainty class of feature-label
distributions [15, 16]. For expression-based classification, prior distributions have
been constructed using expression data not employed in classifier design [14] and
known regulatory pathways [32]. Given that a prior model must be assumed to
achieve satisfactory error estimation, an obvious course of action is to derive an
optimal classifier based on the prior knowledge and the sample data, the result being
an optimal Bayesian classifier (OBC) that is guaranteed to have the best average
performance of any classifier relative to the posterior distribution derived from the
prior distribution and data [19, 20]. While Bayesian classification does not depend
on particular distributional forms, closed-form solutions have been derived for the
multinomial model and Gaussian models using linear classifiers for the minimum
mean squared error (MMSE) error estimate [15, 16], the MSE of the error estimate
[17, 18], and an optimal Bayesian classifier (OBC) relative to the prior distribution
[19, 20], the latter being expressed in terms of effective class conditional distributions,
which are expectations relative to the posterior distribution of the class-conditional
distributions. The closed-form solutions depend on particular models (multinomial
and Gaussian) and the existence of conjugate priors, which can be too constraining
for practical applications such as RNA-Seq classification.
Much of the statistical literature concerning classification of RNA-Seq data at-
tempts to address differential expression testing, that is, univariate statistical testing
on an individual gene basis. These attempts typically model RNA-Seq data via neg-
ative binomial [2, 79] and Poisson distributions [70]. In addition, network inference
has been attempted using a hierarchical Poisson log-normal model [33], and clus-
tering of RNA-Seq data points has utilized various approaches [83, 77]. However,
in clinical settings one is often interested in sample classification: the problem of
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classifying the RNA-Seq data from unlabeled patients using a set of labeled training
data. One of the few RNA-Seq-specific attempts towards this goal uses a Poisson
modeling assumption with independent features [89]. The Poisson model is com-
pletely parameterized by its mean and thus is known to exhibit problems in fitting
RNA-Seq data due to the overdispersion typically observed in such datasets.
In this section, we focus on modeling the pipeline that starts with extracting the
gene concentrations from the biological samples and their subsequent processing by
the sequencing instrument [36]. This is accomplished using a hierarchical, multivari-
ate Poisson model (MP). Specifically, gene concentration levels are modeled by a
log-normal distribution and the sequencing instrument sampling of those is modeled
via a Poisson process. This allows us to accurately model the RNA-Seq data overdis-
persion as demonstrated by marginal variance calculations and posterior predictive
model diagnostics in Section 3.2.5. In addition, this hierarchical model allows for
inferring any covariance structure observed between the features.
Whereas Dalton and Dougherty have presented a computational method for non-
linear classifiers in the Gaussian model [14], this still depends upon conjugate priors.
In this work, we remove the constraints imposed by the requirement of a closed-form
solution by developing the optimal Bayesian classifier using a Markov-chain-Monte-
Carlo (MCMC) methodology. This provides a computational framework for calcu-
lating the OBC for any parameterized class conditional-density and any prior distri-
bution. Most notably, this allows us to use distributions designed to closely model
particular datasets and a prior distribution of any form to improve classification per-
formance in small-sample settings, in particular, for RNA-Seq-based classification.
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3.2 Methods
3.2.1 Notation
Throughout, we use capital letters to indicate random variables, lower case letters
to indicate individual realizations of random variables or indices, bold latin charac-
ters for observed vectors, and Greek letters for latent features and parameters. We
write p(X) as the probability measure over the random variable X. p(X) may be
a probability mass function, probability density function, or arbitrary probability
measure. p(x|y) denotes the conditional probability p(X = x|Y = y). Similarly,
following Bayesian convention, we write parameterized distributions by conditioning
on the parameter, for instance, p(X|Y, θ), and posterior expectations by condition-
ing on the sample, such as E[X|Y, Sn], where Sn and all other values are defined in
Section 3.2.2. If it is unclear which density an expectation is taken with respect to,
then we denote it in subscript notation, such as Eθ|Sn [·], where the expectation is
taken with respect to the density p(θ|Sn).
3.2.2 Review of optimal Bayesian classification
Binary classification considers a set of n labeled training data points, Sn =
{(x, y)}n1 , where y ∈ {0, 1} is the class label and x ∈ X is the feature vector over
a feature space X . An example of binary classification in a clinical setting might
include class 0 and 1 being two types of cancers, or normal and cancerous tissues.
Available features would then be the gene or genes that will eventually be used in
the designed classifier to assign this label. The feature space X would be the set
of possible gene expression measurements for all genes in the feature vector. The
labeled training data Sn would be the set of gene expression measurements from
samples which had undergone further testing (possibly observation with the passage
of time, cell culturing, or more invasive followup procedures) to identify the type or
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malignancy of the tissue. Using Sn, we design a classifier ψ that hopefully performs
well on the unknown joint feature-label distribution p(X, Y ). In the same clinical
example, the classifier ψ could then identify the type of cancer using gene expression
measurements alone.
By parameterizing this unknown joint distribution in a model-based Bayesian
framework one can derive an optimal Bayesian classifier (OBC) that minimizes the
expected error over the space of all classifiers under assumed forms of the class-
conditional densities. Specifically, under Gaussian and multinomial class-conditional
densities and their corresponding conjugate prior distributions, closed-form solutions
for the OBC [19, 20] and the first two moments of the error estimate conditioned on
the sample [17, 18] have been obtained.
The parameterization of the feature-label distribution consists of the marginal
class probability c and the class-conditional densities p(x|y, θy), where a particular
value θy ∈ Θy specifies a single class-conditional density contained in the class of
densities defined over the space Θy, which will be a Cartesian product as described
in Section 3.2.4. Therefore, for a two-class problem, we specify a parameterized joint
feature-label distribution as θ = (c, θ0, θ1) ∈ Θ = [0, 1] × Θ0 × Θ1. In the Bayesian
classification framework, these values are then treated as random variables, so that
we may consider quantities such as the expectation of c, or another random variable
conditioned on the value of the parameter vector θ.
Fig. 3.1 describes the inter-relationships between the quantities of interest in the
general theoretic framework of Bayesian classification. The tree shows a subset of
the derivations possible from the posterior feature-label parameter distribution to
the OBC classifier and error estimates. Specifically, directed edges indicate that
the child can be derived from the parent by performing the operation indicated
by the edge label. Closed-form solutions of the quantities highlighted in grey have
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Figure 3.1: A Bayesian classification derivation tree summarizing the relationships
between several important quantities in the general theoretical framework of Bayesian
classification. A directed edge between a parent and its child indicates that the child
can be derived from the parent by the equations indicated in the edge label. The root
of the tree p(θ|Sn) is the posterior distribution of the feature label parameters and by
taking expectations with respect to this distribution, we can derive the effective class
conditional densities p(x|y, Sn) and the distribution of the classifier error p(ε|Sn).
Then these quantities give rise to the OBC, and MMSE and MSE estimates for the
error as described in the text. Quantities highlighted in grey are given in closed form
for Gaussian and multinomial distributions in [17]. Reproduced with permission
from [57].
been calculated for the Gaussian and multinomial feature-label distributions [15, 16].
As in those derivations, the tree assumes independence between the marginal class
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probability c and the class-conditional parameters θy. In addition, the posterior of c
is assumed known throughout the tree. Fig. 3.1 demonstrates a primary benefit of
the Bayesian approach to classification. Once we obtain the posterior distribution
of the class-conditional parameters, it is straightforward to calculate many relevant
quantities through appropriately crafted conditional expectations. In this section
we demonstrate how to approximate any quantity in the tree for arbitrary class
conditional densities and arbitrary prior distributions.
We now examine the tree in more detail. Starting at the far left of the tree,
p(θ|Sn) is the posterior distribution of the parameterized feature-label distribution
– posterior to the labeled samples in Sn. Typically, error estimates and the optimal
classifier are our primary interest, so that this posterior distribution is traditionally
used as a means to compute other quantities and is not of interest by itself.
The effective class-conditional density is the marginal predictive posterior of the
feature vector X conditioned Sn and the class variable Y ,
p(x|y, Sn) =
∫
Θy
p(x|y, θy)p(θy|Sn)dθy. (3.1)
It gives the distribution of the feature vector using a weighted average over all the
parameterized class-conditional densities in Θy given a class y. The weights in this
expectation are the posterior, p(θy|Sn), evaluated at each θy.
The true error of classifier ψ is ε = p(ψ(X) 6= Y ). Given the sample data Sn, ε is
a random unknown quantity in the Bayesian framework. The MMSE estimate given
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in [17] can be written as
E[ε|Sn] = p(ψ(X) 6= Y |Sn)
= Eθ|Sn [p(ψ(X) 6= Y |θ, Sn)]
= cˆε0(θ0, ψ) + (1− cˆ)ε1(θ1, ψ)
=
∫
X
(cˆp(x|0, Sn)Ix∈R1
+ (1− cˆ)p(x|1, Sn)Ix∈R0)dx, (3.2)
where IA is the indicator function for event A, cˆ = E[c|Sn] is the posterior expectation
of c, Ry is the region of the feature space the classifier predicts to be class y, X is
the feature space, and εy(θy, ψ) is the error of classifier ψ contributed by class y on
the fixed distribution θy.
We can also obtain the full posterior distribution of the error,
p(ε|Sn) =
∫
Θ
p(ε|θ)p(θ|Sn)dθ
= Eθ|Sn [p(ε|θ)], (3.3)
where p(ε|θ) is the true error for a fixed feature-label distribution and fixed classifier.
We denote this deterministic function by ε(θ, ψ). As shown in Fig. 3.1, the MMSE
estimate and the sample conditioned MSE for this error can also be calculated using
the first two moments of the error distribution.
With the MMSE estimator defined, the optimal Bayesian classifier (OBC) is the
classifier minimizing the expected error by pointwise minimization of the integral
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(3.2) [20]:
ψOBC(x) =

0 if cˆp(x|0, Sn) ≥ (1− cˆ)p(x|1, Sn),
1 otherwise.
. (3.4)
3.2.3 Conditional error estimator
If the true feature-label distribution were known, then we could compute the true
error of a classifier exactly as an expectation over the conditional error [30]:
ε = p(ψ(X) 6= Y ) =
∫
X
p(ψ(x) 6= Y |x)p(x)dx.
Treating ε as a random variable, one can similarly derive its posterior distribution
by conditioning on the feature vector:
p(ε|Sn) =
∫
X
p(ε,x|Sn)dx
=
∫
X
∫
Θ
p(ε, θ,x|Sn)dθdx
=
∫
Θ
p(θ|Sn)
∫
X
p(ε|x, θ)p(x|Sn)dxdθ, (3.5)
which is different than the derivation of the same quantity in (3.3).
This introduces the idea of the conditional error estimator, which we define as
the MMSE estimate of the classification error conditioned on the feature vector x,
εˆ(ψ,x) = Eθ|Sn [ε|x, Sn]
= p(ψ(x) 6= Y |x, Sn) (3.6)
=
p(x|Y 6= ψ(x), Sn)p(Y 6= ψ(x)|Sn)
p(x|Sn)
= Z−1p(x|Y 6= ψ(x), Sn)p(Y 6= ψ(x)|Sn),
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as expanded through application of Bayes’ theorem, where Z is a normalizing con-
stant given by
Z = p(x|Sn) =
∑
y∈{0,1}
p(x|y, Sn)p(y|Sn).
In addition to being useful in the above alternative derivation of the classifier’s
error posterior, the conditional error estimate has other practical applications. When
classifying an unlabeled data point, we would like to estimate the error of the classifier
output for that particular data point, as opposed to the overall error estimate for
the classifier.
For the OBC, from (3.4) the conditional error estimator can be written as
εˆ(ψOBC,x) = Z
−1 min
y∈{0,1}
{p(x|y, Sn)p(y|Sn)} . (3.7)
In sum, using the effective class-conditional densities and the posterior marginal
probabilities one can calculate conditional error estimates for points in the feature
space in addition to the earlier quantities described.
3.2.4 The multivariate Poisson model
With the widespread use of next-generation sequencing techniques, classification
approaches must be developed to account for the discrete nature of the mapped
sequence data and to accommodate the various types of prior information available
regarding these experiments.
Gene concentration levels can be modeled using a log-normal distribution [5, 4].
As discussed in the introduction, we assume that the sequencing instrument samples
this mRNA concentration through a Poisson process and obtainsXi,j reads for sample
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point i and gene j. We model this as
p(Xi,j|λi,j) ∼ Poisson(di exp(λi,j)), (3.8)
where λi,j is the location parameter of the log-normal distribution for sample i and
gene j, and di is a variable accounting for the sequencing depth as determined by
the sequencing process [36]. For each i, we model the location parameter vector λi
with a multivariate Gaussian distribution, λi ∼ Normal(µ,Σ). We then consider the
mean µ and covariance Σ of the gene concentrations as independent quantities for
each class y.
The entire MP model is represented in Fig. 3.2 as a plate diagram. The distribu-
tion of a single class y is parameterized by θy = (µ,Σ,d, λ), where d = (d1, . . . , dn)
and λ = (λi,j), i = 1, 2, ...n, j = 1, 2, ..., D, for n sample points and D total genes.
Therefore, θy ∈ Θy = RD × RD×D × Rn × RD×n. The feature-label distribution
parameterization for the two-class problem is then given by θ = (c, θ0, θ1), where
c = p(Y = 0), the prior probability for class 0.
To ensure a proper posterior with unit integral, we place weakly informative
priors over the latent variables in the MP model. In choosing these values, we have
aimed to avoid the complications that can occur with overly diffuse priors, such as
Lindley’s paradox [68, 82]. We choose:
µy ∼ Normal(ηy, ν2ID)
Σy ∼ Inverse-Wishart(κy, Sy)
c ∼ Beta(1, 1),
where each element of µy is distributed according to a univariate Gaussian. Unless
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Figure 3.2: Mutivariate Poisson model plate diagram. A plate diagram for the
multivariate Poisson model. The outermost plate represents the classes that we are
interested in classifying against, where i is the index of the sample in class y, and j
are the genes being modeled. Reproduced with permission from [57].
otherwise stated, η is the D dimensional zero vector, ν2 = 25, κ = 10, and S =
(κ − 1 − D)ID. For computational and identifiability reasons, d is fixed to be a
vector of normalization constants in order to match the different sequencing depths
across all the samples. In practice, d can be approximated by an upper quartile
normalization, which has been shown to be effective [25].
In any Bayesian approach the choice of prior affects the results, especially when
only a few data points are given. In the case of MMSE classifier error estimation
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in the Bayesian framework, robustness to incorrect modeling assumptions has been
extensively studied in [16] and in those studies performance held up well for various
kinds of incorrect modeling assumptions. Robustness of optimal Bayesian classifiers
to false modeling assumptions was extensively studied in [20]. Again, good robust-
ness was exhibited. Of course, one can get bad small-sample results by intentionally
selecting an inaccurate prior. In general, if one is confident in his knowledge, then
a tight prior is called for because tighter priors require less data for good perfor-
mance; on the other hand, when one is not confident, then prudence calls for a less
informative prior. As proven in [20], OBC classification is consistent under very
general conditions; however, a prior whose mass is concentrated far away from the
true parameters will perform worse than one that is non-informative. These issues
have been extensively discussed in the Bayesian literature [50, 51, 6, 32]. In the end,
performance is the measure of worth and our results with synthetic and real data
indicate solid performance for the modeling approach used herein.
3.2.5 Overdispersion
The MP model uses the Poisson distribution in a hierarchical scheme. It is
important to note that, while the read counts are modeled as conditionally Poisson
in equation 3.8, the observed read counts are not marginally Poisson distributed.
To demonstrate this, consider a one-dimensional simplification of the MP model in
which X is the number of reads observed,λ is the log of the RNA concentration, and
λ ∼ Normal(µ, σ2)
X ∼ Poisson(exp(λ)).
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Then for the marginal variance of X,
Var(X) = E[Var(X|λ)] + Var(E[X|λ])
= e(µ+σ
2/2) + (eσ
2 − 1)e(2µ+σ2)
≥ eµ = Var(Poisson(eµ))
where µ and σ2 are the mean and variance of the log of the concentration. Therefore,
when σ2 > 0, the marginal variance of X is always greater than that of a Poisson
random variable with the same effective rate.
In addition, by carrying out a posterior predictive model check [34, p. 143] by
computing marginal posterior p-values against real RNA-Seq data, we can quanti-
tatively assess the ability of the MP model to fit the dispersion of the TCGA data.
For a test statistic T , we compute the p-value by comparing the test statistic on the
true data T (Sn) and the value of the statistic averaged across the posterior predictive
distribution T (xrep), where xrep ∼ p(x|Sn):
pT = Pr(T (xrep) ≥ T (Sn)|Sn)
= Pr(T (xrep) > T (Sn)|Sn)
+ (0.5)Pr(T (xrep) = T (Sn)|Sn)
≈ 1
M
M∑
i=0
I{T (xrep(s)) > T (Sn)}
+ 0.5I{T (xrep(s)) = T (Sn)},
where xrep(s) are Monte Carlo samples taken from the posterior predictive distribution
p(x|Sn) using the M Monte Carlo samples from the posterior distribution of θ as
described in Section 4.2.2. The term (0.5)Pr(T (xrep) = T (Sn)|Sn) is necessary due
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to the discrete nature of RNA-Seq data. P-values away from 0 and 1 indicate that
the model posterior produces test statistics both above and below that measured on
the real data.
We also consider where the real test statistic falls in relation to credible intervals
of the test statistic to consider the magnitude of any differences. We apply the inter-
quartile distance test statistic to provide a measure of the MP model’s ability to fit
the dispersion of RNA-Seq data. We also consider several other test quantities in
Appendix C.
3.2.6 Prior calibration using discarded features
Since designed classifiers typically use very few of the totality of observed genes,
only a small fraction of the data is used for classifier design. Similarly to [14], we can
use the discarded features to calibrate the inverse-Wishart prior for our MP OBC.
Our goal is to obtain hyperparameters S,m, κ, and ν2 for each class from our training
data Sn. In general, we do not expect the discarded features to give us information
about any particular genes and the specific covariances between genes, so we make
the simplifying assumptions that we learn information from the discarded genes in an
aggregate sense. Thus, we consider the following structure on the hyperparameters:
m = m[1, 1, . . . , 1]T and
S = σ2

1 ρ · · · ρ
ρ 1 · · · ρ
...
... . . .
...
ρ ρ · · · 1

,
where m ∈ R, σ2 > 0, and −1 ≤ ρ ≤ 1. For each class, we need to determine values
for five scalar quantities: m, ν2, σ2, ρ, and κ.
Due to the hierarchical design of the MP model, we cannot apply the method
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of moments in a direct fashion, as did [14]. Instead, we utilize a sampling based
approach to the method of moments. This MCMC sampling approach has been
examined in [9] as an extension to the generalized method of moments [42]. The
sampling approach uses the discarded features in an additional MCMC run evaluated
prior to the primary classification MCMC procedure as discussed in Section 4.2.2
– and then proceeds to the method of moments. In this calibration MCMC, we
initialize all prior distributions with flat priors and use the discarded features to
obtain samples from the posterior distribution of µ and Σ. Typically, the number of
discarded features F is much larger than the dimensionality D of the classification
problem. Therefore, due to computation time, we uniformly sample Fs pairs of
features from F and average the resulting runs rather than using all or large groups
of discarded features in a single MCMC run. We use the following procedure (for
the complete algorithm, see Appendix A):
1. For each randomly chosen discarded feature pair (s in total):
(a) Obtain MCMC samples using the feature pair as data and flat priors.
(b) Record posterior averages of µ and Σ.
2. Average over these posterior averages as given by eqs.(3.15)-(3.19).
3. Using the resulting five hyperparameter estimates, run the final MCMC for
classification.
Following [14], we use the moments of the posterior samples to determine the
hyperparameters through the following relations: The mean of an inverse-Wishart
distribution is
E[Σ] =
S
κ−D − 1 , (3.9)
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which together with our simplified covariance structure implies
σ2 = (κ−D − 1)E[Σ11], (3.10)
ρ =
E[Σ12]
E[Σ11]
. (3.11)
The variance of the first diagonal of an inverse-Wishart matrix can be used to solve
for κ via
κ =
2(E[Σ11])2
Var(Σ11)
+D + 3. (3.12)
As we have samples of µ directly from our posterior, we obtain
m = E[µ1], (3.13)
ν = Var[µ1]. (3.14)
In order to use equations (3.9)-(3.14), we obtain estimates of the moments from
MCMC performed over the Fs discarded feature pairs. For the i-th feature pair we
obtain the posterior means µ̂(i)1 , Σ̂
(i)
11 , and Σ̂
(i)
12 and then average:
Ê[µ1] =
1
Fs
Fs∑
i=1
µˆ
(i)
1 (3.15)
V̂ar[µ1] =
1
Fs − 1
Fs∑
i=1
(Ê[µ1]− µˆ(i)1 )2 (3.16)
Ê[Σ11] =
1
Fs
Fs∑
i=1
Σˆ
(i)
11 + Σˆ
(i)
22
2
(3.17)
Ê[Σ12] =
1
Fs
Fs∑
i=1
Σˆ
(i)
12 (3.18)
V̂ar[Σ11] =
1
Fs − 1
Fs∑
i=1
(Ê[Σ11]− Σˆ(i)11 )2. (3.19)
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We substitute the estimates from Eqs. (3.15)-(3.19) back into Eqs. (3.9)-(3.14) to
obtain the final hyperparameter estimates.
One must keep in mind that the calibration procedure explicitly assumes the MP
model. Hence, one can only expect an improvement in the classification performance
if the data follow the MP model.
3.2.7 Computation
To obtain the MP OBC, we approximate the effective class conditional densities
in order to minimize the expected error in a pointwise fashion:
p(x|y, Sn) =
∫
Θy
p(x|y, θy)p(θy|Sn)dθy
≈ 1
M
M∑
i=1
p(x|y, θ(i)y ), (3.20)
where θ(i)y are M samples of θy from the model posterior distributions.
For clarity of presentation, we do not consider the class variable y, and we assume
a single class. We do this because the computation can be performed per-class
due to the assumed independence between the classes and the marginal probability,
p(c, θ0, θ1) = p(c)p(θ0)p(θ1).
To obtain posterior samples of θ using the Metropolis Hastings MCMC algorithm
we define a proposal distribution p(θ′|θ) to obtain a new value for the class parameters
θ′ from the old values θ. We then calculate the acceptance ratio
R = min
{
1,
p(θ′|Sn)p(θ′|θ)
p(θ|Sn)p(θ|θ′)
}
= min
{
1,
p(Sn|θ′)p(θ′)
p(Sn|θ)p(θ)
}
,
under the assumption of a symmetric proposal distribution (p(θ′|θ) = p(θ|θ′)). The
process of proposing and accepting samples from this distribution with the proba-
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bility R induces a Markov chain. Positivity of the proposal distribution (p(θ′|θ) > 0
for any θ) is a sufficient condition for ergodicity of this Markov chain. Furthermore,
this Markov chain admits a steady-state distribution equal to our desired posterior
distribution p(θ|Sn) [38].
From the definition of the likelihood,
p(Sn|θ) =
n∏
i=1
p(xi|θ) =
n∏
i=1
p(xi|λi)
=
n∏
i=1
D∏
d=1
p(xi,d|λi,d),
where p(xi|θ) = p(xi|λi) owing to conditional independence. From the definition of
the prior,
p(θ) = p(µ,Σ, λ)
= p(λ|µ,Σ)p(µ|Σ)p(Σ)
=
n∏
i=1
p(λi|µ,Σ)p(µ|Σ)p(Σ).
The posterior predictive distribution in (3.20) is approximated by
p(x|Sn) ≈ 1
M
M∑
i=1
p(x|θ(i))
=
1
M
M∑
i=1
∫
Λ
p(λ|θ(i))p(x|λ)dλ
=
1
M
M∑
i=1
∫
Λ
p(λ|θ(i))
D∏
k=1
p(xk|λk)dλ
≈ 1
MT
M∑
i=1
T∑
g=1
D∏
k=1
p(xk|λ(g)k ),
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where, p(xk|λk) ∼ Poisson(dk exp(λk)), λ ∼ Normal(µ,Σ), Λ = Rn×D, and the λ(g)
are T vector-valued samples drawn from the appropriate class’s posterior distribu-
tion used to approximate the inner intractable integral. In addition, we use this
approximation of the effective class-conditional density to calculate the conditional
error estimates of (3.7) in a pointwise fashion.
Finally, because we have assumed a conjugate prior distribution for the marginal
class probability c, the posterior expectation takes the closed form
Eθ|Sn [c] =
n0 + α0
n0 + n1 + α0 + α1
,
where the ny are the number of training samples obtained from class y and the αy are
hyperparameters set to 1 for an uninformative prior. Conjugacy was used for this one
parameter because the increased flexibility of the full sampling approach was deemed
not necessary due to the constrained, univariate nature of the parameter. If more
complex relationships between c and other parameters were desired, then a sampling
approach using non-conjugate priors would be straightforward to implement.
3.2.8 Synthetic data
To evaluate OBC performance in the setting of the MP model, we generate syn-
thetic data using the method proposed in [47] to simulate gene expression/mRNA
concentrations (see Appendix B). These gene expression values are then statistically
sampled to emulate modern sequencing machines as described in [36]. Parameter
values are drawn from the following distributions to examine a wide variety of clas-
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sification problems:
µy ∼ Normal(0, 0.2),
σy ∼ Inverse-Gamma(1, 3),
ρ = Uniform(0.0, 1.0),
dlow = 9,
dhigh = 11,
blocksize = 5.
With these parameters, ten global, twenty heterogeneous, and ten non-marker
features are generated. Then four features are randomly chosen to represent a mix-
ture of features of various classification quality. Following [36], the features in the
data are zero mean and unit standard deviation normalized except for the MP OBC.
The exception occurs because the MP model expects features to be positive integers
and normalization is not necessary. The discarded features are used for calibration
of the MP OBC priors, and 3000 samples are generated from each class to estimate
the true classification rate for each classifier.
We use four features in this synthetic data classification study owing to limited
computational resources as discussed in Section 3.3.3.
The synthetic data generation method proposed in [47] imposes the strong as-
sumption of a homogeneous covariance (HC) structure between the two classes of
data. This assumption does not hold for biological situations where interactions
between features are not necessarily preserved between classes, and this occurs fre-
quently in biology when considering the possible effects of canalizing genes, nonlinear
gene regulation, and mutations in the case of cancer [71, 28]. Specifically, if the canal-
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izing gene is not observed, and differs in activity between the two classes, then the
measured correlation between two downstream genes could potentially be negligible
in one class while strong in the other class. Similarly, for highly nonlinear gene reg-
ulation, if a gene in one class is in the saturation region of its response curve from
a master gene, then the correlation will be low, while a lower expression level in
the other class would allow for a large measured correlation with the same canaliz-
ing gene. And finally, if one class represents normal gene expression and the other
tumor-related expression, then a correlation might exist from a functioning pathway
in the normal tissue, but a mutation could result in a lack of correlation effects in
the tumor.
Hence, we modify the synthetic data generation procedure in an attempt to pro-
duce synthetic datasets more representative of such nonlinear phenomena in biology.
In this modified procedure, we allow independent covariance (IC) matrices for the
features of the two classes. To generate these covariance matrices, Σy, we utilize inde-
pendent draws from inverse-Wishart distributions with parameters κy = 22, D = 20,
and scale matrix S = σ2y(κ− 1−D)ID. To examine the effects of feature correlation
in IC datasets, we can also generate low-correlation covariance matrices by zeroing
the off-diagonal terms. Once the covariance matrix for class y is obtained, location
parameters for gene-expression values for each sample point are drawn from the re-
spective multivariate normal distribution λy ∼ N(µy,Σy). Each sample point is then
assumed to be normalized through an upper quartile or other suitable method, but
in practice any sample-based normalization is imperfect. We reflect this variation by
drawing the sequencing depth di from a Uniform(dlow, dhigh) distribution, giving the
rate of the Poisson process as di expλi. The number of reads for a single gene from
a single sample is then drawn from this Poisson distribution. See Appendix A for
more detail.
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The OBC is optimal on average across the space of distributions determined by
its prior distributions. To avoid biasing the performance comparison, we draw the
classification problem datasets using different distributions than those of the OBC
priors. See Appendix A for more detail.
3.2.9 Real data
We consider a real RNA-Seq dataset composed of level 3, RNASeqV2 data from
the Cancer Genome Atlas (TCGA) project. It contains 484 and 470 specimens from
lung adenocarcinoma and lung squamous cell carcinoma tumor biopsies, respectively.
The samples are mapped read counts against 20531 known human RNA transcripts
as generated by the University of North Carolina at Chapel Hill, one of the Genome
Sequencing Centers for the TCGA. The data for each cancer type is the result of
processing approximately 20 billion reads and the read count files for each are one
gigabyte apiece. The problem is to classify the tumor types. Because the class-0
(lung adenocarcinoma) and class-1 (lung squamous cell carcinoma) sample sizes, 484
and 470, are not chosen randomly, we are confronted with the problem of separate
sampling. This means that there is no way to obtain a posterior distribution for c and
therefore cmust be known in advance. Based upon records from 2006-2010, we have a
very accurate estimate, 48, 600/141, 300 ≈ 0.34 [78]. Whereas we can use the value of
c directly, along with all of the data, in designing the OBC, for classification rules that
do not use c explicitly, the separately sampled data must be maximally subsampled
to the proper sampling ratio c before applying the classification rule [31]. This means
that for Ntrn desired samples, the sample subsets will contain round((1−c)Ntrn) and
round(cNtrn) for class 0 and 1, respectively. Moreover, holdout error estimation,
which we use here, must be properly adapted for separate sampling for all design
methods, including the OBC. The holdout estimate is given by
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εˆc = cεˆ0 + (1− c)εˆ1,
where εˆ0 and εˆ1 are the ordinary holdout estimators (performed on all remaining
data samples not used for training) for the class-0 and class-1 errors, respectively
[31]. We note that many studies have made the mistake of using classification rules
designed for random sampling when sampling is separate. This can have devastating
effects on classifier performance [31].
While averaging over sample subsets for holdout error estimation, we also average
over uniformly, randomly selected gene subsets of size 4. This sampling occurs from
low (1-10 average reads per gene) expression genes. We sample from these lower
expression genes because we are ultimately interested in classification problems where
the delineation between phenotypes is determined by genes with low expression.
We used 10,000 for averaging in order to obtain a large enough sample over this
feature and sample subset space to achieve repeatable results (data not shown).
Computational runtime for each sample and gene subset was similar to the synthetic
data.
3.3 Results and discussion
Appendix A contains a simple two-class, two-feature demonstration of the overall
procedure to allow for easy visualization and interpretation. Here we discuss the
results for the synthetic and real data.
3.3.1 Synthetic data
To evaluate classification performance, classifiers were trained using 3NN, LDA,
and c-support vector machines with a radial basis function kernel [30]. Starting
with the homogeneous-covariance model, Fig. 3.3a shows that the performance of
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Figure 3.3: Synthetic data classification results with (a) homogeneous-covariance, (b)
high correlation independent-covariance, (c) low correlation independent-covariance,
and (d) high correlation independent-covariance data at several problem difficulties.
Reproduced with permission from [57].
the multivariate Poisson OBC is better than nonlinear SVM when more than 10
samples are available and is significantly better than any other classifier when using
calibrated features. Equivalently, by using discarded features, we can obtain the
same classification performance while requiring fewer training samples.
In the case of independent-covariance data with highly correlated features, Fig. 3.3b
shows superior classification performance of the MP OBC at nearly all sample sizes
considered. In addition, for calibrated prior distributions, the performance of the MP
OBC improves. This improvement is greater when the sample sizes are small, which
demonstrates the importance of additional knowledge (through discarded features)
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when data are expensive to obtain or not readily available.
The superior performance of the OBC relative to LDA, 3NN, and SVM in Fig.
3.3b is on account of classification optimization relative to the model, which char-
acterizes prior information. To further investigate OBC improvement, we again
considered heterogeneous covariance matrices but with independent features to de-
termine if there is any difference in the relative performance between the classifiers.
In fact, the results provided in Fig. 3.3c show identical relative performance to the
error curves in Fig. 3.3b, thereby indicating that both the standard classifiers and
the OBC, relative performance (at least in the case considered) is not affected by
whether or not the features are correlated. Indeed, comparing Fig. 3.3a with Figs.
3.3b and 3.3c, we see that the relative performance of SVM, MP OBC, and cali-
brated MP OBC is the same in both the homogeneous and heterogeneous models.
The switch in relative performance between LDA and 3NN between Fig. 3.3a and
Figs. 3.3b and 3.3c is not surprising because LDA is optimal for a fixed (known)
homogeneous Gaussian model but not for a heterogeneous Gaussian model.
The larger overall classification errors in Fig. 3.3a as compared to Figs. 3.3b
and 3.3c are due to the different covariance matrices generated by the HC and IC
models. Each model required different generating distributions for {σy, ρ} and {S, κ}
for the HC and IC cases, respectively, and the particular choices made in Section
3.2.8 resulted in larger dispersions and higher errors in the HC models than the IC
models. To demonstrate this, we tested LDA with 1000 training and testing samples
across 1000 random generating distributions and found the average HC classification
error to be 0.41 and the IC error to be 0.32. This is despite LDA being optimal for
homogeneous, fixed, known Gaussian cases and sub-optimal for heterogeneous, fixed,
known Gaussian cases, where the former is similar to the HC case.
These differences in overall error rates are also consistent with the intuition that
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larger differences between class covariance matrices induce higher classification error
rates. This is seen in: the low classification error rates in Fig. 3.3c where all elements
of the covariance matrices are not shared between the two classes, the high error rates
in Fig. 3.3a where the covariance matrices are identical between the two classes, and
the error rates of Fig. 3.3b falling in between the previous two figures where only the
diagonal elements of the covariance matrices differ between the two classes and all
off-diagonal elements are shared (and zero).
Still using independent-covariance data, we fixed the mean of class 0 at µ0 = 0.0 in
Fig. 3.3d, and varied µ1 from 0.0 to 1.0 to make the classification problem harder and
easier, respectively. Across this range of classification problems, the MP OBC had
better classification performance than the other classification methods. In addition,
calibrated priors improved performance further, especially for harder classification
problems.
3.3.2 Real data
In Table 3.1, we chose ten genes at random from adenocarcinoma tumor TCGA
samples and performed model diagnostics [34, p. 143] by calculating posterior pre-
dictive p-values for interquartile distance (IQR) as a measure of dispersion. In the
Appendix C, we provide additional test statistics and graphical predictive posterior
model diagnostics. These results indicate that RNA-Seq overdispersion is modeled
sufficiently with the MP model.
In Fig. 3.4, we see mean holdout errors averaged over 10,000 training sets and
testing sets of TCGA data as described in Section 3.2.9. Here the MP OBC performs
better than all other classifiers across most training sample sizes considered, but
calibration does not improve performance for this particular dataset. Recall that
improvement owing to calibration depends on the extent to which the data satisfy
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Table 3.1: Posterior predictive model diagnostics are given for 10 randomly selected
genes from adenocarcinoma TCGA samples. Inter-quartile distance (IQR) is used
as a robust measure of dispersion. In the table, IQR(Sn) is the training data’s IQR,
followed by the 95-th credible interval, and the posterior predictive P-value. In cases
where the P-value is close to 0 or 1, the true test statistic’s distance from the 95-th
credible interval can be used to determine the magnitude of the mis-fit. Reproduced
with permission from [57].
Gene ID IQR(Sn) 95% int. for IQR(xrep) p-value
UPK1A|11045 2.12 [1.0, 3.0] 0.09
OR4P4|81300 0.00 [0.0, 0.0] 0.50
PCDHA12|56137 139.22 [107.8, 187.0] 0.54
MDS2|259283 1.85 [2.0, 5.0] 1.00
AXIN2|8313 347.69 [331.5, 439.3] 0.85
DYNLT1|6993 848.41 [830.0, 1043.3] 0.90
RARA|5914 786.43 [706.8, 881.3] 0.62
TMEM194A|23306 396.06 [367.0, 471.3] 0.76
AGPS|8540 496.45 [505.8, 636.5] 0.97
NLRP2|55655 854.47 [381.3, 677.5] 0.00
the MP model. If the aim of this section were to build an operational classifier
based on the TCGA data, then we would have to go back and extensively study the
data set to examine deviations from the model – for instance, outliers; however, here
our aim is to show the functionality of the OBC with non-Gaussian data based on
MCMC and apply it to the MP model. The fact that the MP OBC performs well
on the real data satisfies this aim. Calibration is a tricky business and it would be
a major separate study to characterize the manner in which model variation affects
calibration, even if we were to perform an intensive study of this particular data set.
Performance on the synthetic data demonstrates the effectiveness of the calibration
when the model is satisfied.
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Figure 3.4: TCGA RNA-Seq Classification. Average holdout errors were computed
over 10,000 training sets and feature subsets using two types of lung cancer RNA-
Seq data from TCGA. MP OBC with and without calibrated priors demonstrates
superior performs across a range of training sample sizes. In addition, providing
the MP OBC with calibrated priors does not appear to improve performance in this
particular dataset. Reproduced with permission from [57].
3.3.3 Computational limitations
The results in Fig. 3.3 and Fig. 3.4 required tens of thousands of MCMC runs.
Owing to limited available computational resources, we could only allocate around 30
seconds on a single CPU core for each MCMC run. This necessitated using only four
genes for these classification results as each iteration of the MCMC procedure has
time complexity of O(D3), where D is the number of features. In practice, one would
have a small number of data sets and could use parallel computing to devote more
time and computing effort for the classification. For example, in timescales on the
order of hours on a typical workstation, we have successfully performed classification
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using 50 genes.
The other classification methods compared in this study have smaller computa-
tional requirements and can correspondingly handle larger numbers of features given
the same available resources. However, for the small sample sizes often available
in biology, 50 genes is typically beyond the “peaking” point where most classifiers
decrease in classification performance as more features are added (for a fixed num-
ber of training samples) [48]. Incidentally, the OBC does not suffer this “peaking
phenomenon” as shown in [19].
In addition, the computational time requirements of classification is typically
not a bottleneck in translational medicine given the timescales used in collecting
biological data. In these settings, the accuracy of classification is much more valuable
than rapid runtimes, and this is the primary advantage of the computational OBC
framework proposed in this section.
3.4 Conclusions
We have demonstrated that Bayesian classification can be applied to specific
problem domains such as RNA-Seq through statistical modeling and MCMC compu-
tation. The resulting classifier provides superior classification performance compared
to state-of-the-art classifiers such as SVM with a radial basis kernel. Although we
have not discussed error estimation – our interest in the present section being clas-
sification, ipso facto, the MCMC approach to optimal Bayesian classification can be
applied, via [15, 16] and [17, 18], to obtain optimal MMSE error estimators for any
classification rule and sample-conditioned evaluation of the MSE for error estimation.
In the next section, we extend this work to the error estimation in the optimal
Bayesian error estimate and mean square error of the Bayesian error estimate. We
then use these two estimators for feature selection as a method to find gene sets
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which well separate biological phenotypes.
67
4. DETECTING MULTIVARIATE GENE INTERACTIONS IN RNA-SEQ
DATA USING OPTIMAL BAYESIAN CLASSIFICATION∗
In the previous section, we developed the multivariate Poisson statistical model
of sequencing data and built an Optimal Bayesian Classifier relative to that model
for sequencing datasets. In this section, we consider optimal error estimation using
the same hierarchical Poisson model as a biological discovery tool through feature
selection.
4.1 Introduction
RNA-Seq is a high-throughput technique for measuring the gene expression profile
of a target tissue or even single cells. Due to its increased accuracy and flexibility
over microarray technologies, it is widely applied in biological fields to uncover the
transcriptional mechanisms at play in a given physiology or phenotype.
Typically, this analysis involves mapping the RNA-Seq reads to a reference genome,
quantifying transcript expression, and then performing testing for differential gene
expression to determine which genes are expressed at significantly different levels in
the phenotypes being compared. Tools such as Cuﬄinks [86], edgeR [79], and DE-
Seq2 [69] provide these univariate statistical tests using well characterized univariate
statistical models of gene expression.
However, one is often interested in phenotypes which can only be differentiated by
the state of several genes simultaneously. These multivariate relationships cannot be
detected using univariate testing procedures only. Instead, it is necessary to consider
the joint expression patterns between multiple genes simultaneously and the ability
∗Parts of this section were reproduced with permission from Knight, J.M.; Ivanov, I.; Dougherty,
E.R. "Detecting Multivariate Gene Interactions in RNA-Seq Data Using Optimal Bayesian Classi-
fication", under review [58] © 2015.
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to use this joint expression to differentiate the phenotypes of interest.
While this problem can be approached using the study of multivariate statisti-
cal testing, we instead opt to utilize the theory of statistical classification for two
primary reasons. First, translational medicine aims to apply scientific knowledge
to improve medical practice, and classification’s prediction of phenotypes from gene
expression data is well aligned with this goal. Secondly, the model-based approach
used in optimal Bayesian classification allows for the use of prior biological knowledge
to improve results in the small number of samples typically available in biological
studies.
Here, we employ the optimal Bayesian classifier and optimal Bayesian error es-
timator to quantify the relationship between the joint gene expression information
and phenotypes of interest. We begin in Section 4.2.1 by reviewing optimal error
estimation with optimal Bayesian classification. Section 4.2.2 explains our approach
to computation using Monte Carlo techniques including Markov Chain Monte Carlo.
Then Section 4.3 describes the dietary intervention study dataset and discusses the
overall study design. Section 4.4.2 discusses the results of the computational study,
and Section 4.4.3 considers the biological implications of the top performing gene
sets.
4.2 Methods
4.2.1 Optimal Bayesian classification
Binary classification considers a set of n labeled training data points, Sn =
{(x, y)}n1 , where y ∈ {0, 1} is the class label and x ∈ X is the feature vector over a
feature space X . Using Sn, we design a classifier ψ based on data from the unknown
joint feature-label distribution p(X, Y ). By parameterizing this unknown joint dis-
tribution in a model-based Bayesian framework one can derive an optimal Bayesian
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classifier (OBC) that minimizes the expected error over the space of all classifiers
under assumed forms of the class-conditional densities [19, 20]. While extending this
framework to the multiple class classification problem is straightforward, this section
utilizes the two-class problem formulation to aid biological interpretation.
We parameterize the feature-label distribution into the marginal class probability
c = p(y = 0) and the class-conditional densities p(x|y,θy), where a particular value
θy ∈ Θy specifies a single class-conditional density and for a two-class problem θ =
(c,θ0,θ1) ∈ Θ = [0, 1] × Θ0 × Θ1. In the Bayesian classification framework, the
components of θ are treated as random variables, so that we may consider quantities
such as the expectation of c, or the conditional expectation of some other quantity
conditioned on the value of the parameter vector θ.
4.2.1.1 The optimal Bayesian error estimate
The true error of a classifier ψ can be written as ε = p(ψ(X) 6= Y ). Given the
sample data Sn, one can utilize a Bayesian framework and compute the posterior
distribution p(ε|Sn). Additionally, one can consider the conditional expectation of
the posterior E[ε|Sn], which is taken with respect to the model posterior distribution
p(θ|Sn). Keeping in mind that, in the Bayesian framework, the true error is a
function of both θ and Sn, this conditional expectation provides an optimal estimate
of the true error of the designed classifier relative to mean-square error (MSE) with
respect to the joint distribution of θ and Sn [15, 16]. This minimum mean-square
error (MMSE) estimate is known as the optimal Bayesian error estimate (BEE) and
is defined by
εˆ = E[ε|Sn] = Eθ|Sn [p(ψ(X) 6= Y |θ, Sn)].
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Optimality follows directly from classical MSE theory. Moreover, according to that
theory the BEE is an unbiased estimate of the true error relative to the sampling
distribution.
With the BEE defined, the optimal Bayesian classifier (OBC) for binary classifi-
cation is given by [19]
ψOBC(x) =

0 if cˆp(x|y = 0, Sn) ≥ (1− cˆ)p(x|y = 1, Sn),
1 otherwise.
where cˆ = E[c|Sn] is the expected posterior marginal class probability. The OBC is
the classifier minimizing the expected error through pointwise minimization.
4.2.1.2 Uncertainty quantification for the optimal Bayesian error estimate
In addition to the BEE estimate, one is often interested in the uncertainty asso-
ciated with the estimate. This quantification of uncertainty captures the inaccuracy
of our modeling assumptions, the noise in the data, and the amount of data that we
possess. It is given by the posterior variance of the error ε:
Var(ε | Sn) = Eθ|Sn [(ε(θ)− εˆ)2]
=
∫
Θ
ε(θ)2p(θ|Sn)dθ − εˆ2.
This conditional variance is equal to the conditional MSE of the BEE (BEEMSE) as
an estimator of the true error given the sample [17]:
MSE(εˆ|Sn) = Eθ|Sn [(εˆ− ε)2|Sn)].
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Section 4.2.2 considers the efficient computation of this quantity.
4.2.2 Computation
Using the multivariate Poisson model of Section 3, the goal is to obtain the OBC,
BEE, and BEEMSE given a labeled RNA-Seq dataset. The posterior distribution
p(θ|Sn) of θ is sufficient for this; however, the hierarchical multivariate Poisson (MP)
model is not conjugate. Thus, no known analytical closed form solution exists and we
must instead sample from the posterior using MCMC utilizing the prior distribution
and likelihood function [57],
p(Sn|θ) =
∏
y
ny∏
i=1
D∏
d=1
p(xy,i,d|λy,i,d),
where Syny are ny number of training samples from class y only, xy,i are feature
values of the training samples from class y, λy are the λ values from class y, and
p(xy,i|θy) = p(xy,i|λy,i) owing to conditional independence. The prior can also be
decomposed using the assumed independence between the classes and conditional
independence between training samples given the model parameters as [57]
p(θ) =
∏
y
n∏
i=1
p(λy,i|µy,Σy)p(µy|Σy)p(Σy).
Using this form of the prior distribution and likelihood, we obtain samples of
θ from the posterior distribution using Adaptive Metropolis-within-Gibbs Markov
Chain Monte Carlo. As in [57], we approximate the effective class conditional density:
p(x|y, Sn) ≈ 1
Tθ
Tθ∑
i=0
p(x|θ(i), y), (4.1)
where θ(i) are the Tθ samples drawn using MCMC. The OBC can then be calculated
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point-wise. The BEE of the OBC can also be determined using the effective class
conditional density:
εˆ =
∫
X
∑
y
Iψ(x) 6=yp(y,x|Sn)dx
=
∫
X
min
y
p(x|, y, Sn)p(y|Sn)dx
However, this integral is difficult to compute numerically due to the time taken to
evaluate the integrand (4.1) and the discrete, yet large, nature of the integration
space, which poses problems for traditional quadrature routines.
Instead, we reconsidered the integrand to obtain
εˆ =
∫
X
min
y
p(y|x, Sn)p(x|Sn)dx
≈ 1
Tx
Tx∑
i=1
min
y
p(y|x(i), Sn)
≈ 1
Tx
Tx∑
i=1
min
y
[
p(x(i)|y, Sn)p(y|Sn)∑
y p(x
(i)|y, Sn)p(y|Sn)
]
,
where the x(i) are the Tx samples drawn from the effective conditional densities from
both classes. This integration is straightforward to compute as drawing from the
effective conditional density is equivalent to the efficient process of drawing samples
from the posterior samples of θ.
73
Samples of θ
Samples of ε
Monte Carlo integration
E[ε|Sn]
MCMC Sampling
For each θ:Draw x ~ p(x|θ)
E[ε2|Sn]
BEEMSEBEE
Approximate ε|θ
For each x:Using all θ samples, calculate the conditional BEE
Monte Carlo integration
Figure 4.1: BEEMSE calculations utilize MCMC sampling from the posterior of θ.
Then for each sample of θ, ε|θ is approximated using a draw of x from p(x|y,θ).
Then the conditional BEE error is computed for each of these in order to form a
Monte Carlo approximation to ε|θ. Then these approximations are again used in a
Monte Carlo integration step to approximate εˆ and E[ε2].
Computing the BEEMSE requires the first moment (εˆ) and the second moment,
E[ε2|Sn] =
∫
Θ
ε(θ)2p(θ|Sn)dθ
=
∫
Θ
[∫
X
∑
y
Iψ(x) 6=yp(y|x,θ)p(x|θ)dx
]2
× p(θ|Sn)dθ.
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Samples of θ
MCMC Samplingfor gene sets of size 3
For each 2 gene projection in[1,2] [1,3] and [2,3]:
For each θ:Select only the dimensions fromthe projection of μ, Σ, and λ
Compute BEE for this projection
Compute BEECompute Minimum
Subtract
Δ
Figure 4.2: Computation of ∆ is sensitive to Monte Carlo approximation error so
naive calculations of each error quantity are inadequate. Instead we used the above
scheme where the main insight is that the BEE computation for each gene subset
must be made using the same MCMC samples of θ but projected down to the
appropriate dimension. This results in the ∆ quantities shown in Fig. 4.8.
By using a Monte Carlo approximation for the above integrals and simplifying for
binary classification,
E[ε2|Sn] ≈ 1
Tθ
Tθ∑
i=0
[
1
Tx
Tx∑
j=0
p(y˘|x(j),θ(i))
]2
,
where y˘ = arg miny p(y|x, Sn). This process is shown in Fig. 4.1.
We now define the quantity ∆ to be the reduction of classification error by adding
an additional feature to the classification problem. Consider a classification problem
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using three genes with εˆ3 = α. Given the classification errors εˆ2(i) for the i classifi-
cation problems using two gene subsets of the three original features, we define
∆ = min
i
εˆ2(i)− εˆ3 (4.2)
Naive computations of ∆ can easily be dominated by the error from Monte Carlo
approximations. A robust way of computing ∆ can be computed using the process
in Fig. 4.2.
4.2.3 Normalization
Normalization of RNA-Seq datasets is important for reproducible differential ex-
pression testing and many methods have been proposed and tested [25]. We com-
puted the upper quartile normalization factor as a surrogate for sequencing depth
and used that quantity for each sample’s d parameter. We call this normalization
approach a “model” based normalization.
To perform draws from the posterior predictive distribution p(x|y, Sn), the mean
of the normalization factor of training samples from class y is used as the value for
the average sequencing depth factor d.
We also compared the classification errors using this method of normalization
against the raw data and a normalized count approach where the upper quartile
normalized counts were scaled up by the average normalization factor and rounded
back to integers. We denote the two approaches as the “raw” and “count” techniques
respectively.
4.2.4 MCMC convergence diagnostics
It is a well understood limitation of MCMC that it is not possible to determine if
the Markov Chain has reached convergence in a finite number of iterations [67]. We
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employ a convergence diagnostic to check against simple forms of non-convergence.
Here we use the Gelman-Rubin statistic [8] and calculate the potential scale reduction
factor (PSRF) for each element of our MP model. We run five parallel MCMC chains,
each with 10000 iterations, 2000 burn-in samples and a 1/50 sub-sampling ratio. We
assume convergence for each element of the MP model when |1−PSRF| < 0.05 [13].
4.3 Dietary intervention study
A preclinical dietary study was carried out to determine the interplay between
poly-unsaturated fatty acids (PUFA) and the short chain fatty acid, butyrate, which
is generated by fiber fermentation in the intestine. Rats were treated with dietary
fish oil plus the fermentable fiber, pectin or with a control (non chemoprotective) diet
containing corn oil plus cellulose. Six rats per treatment group were then injected
with the colon-specific carcinogen azoxymethane (AOM) to investigate protective
dietary effects during cancer progression. Comparisons of particular interest include
the fish oil/pectin and corn oil/cellulose AOM groups (fpa-cca), fish oil/pectin and
corn oil/pectin AOM groups (fpa-cpa), and the corn oil/pectin and corn oil/cellulose
(cpa-cca) AOM groups.
An average of 38M 50bp single-end Illumina reads were obtained per treatment
group with averages of 33M, 42M, and 41M from the fpa, cca, and cpa groups,
respectively. Spliced alignment was performed against the rat genome (rn5) using
the STAR aligner [26], and the resultant alignments were further processed with
HTSeq-count [3] to perform reference annotation-based transcript assembly using
standard parameters. Differential expression analyses were performed with edgeR
[79] and DESeq [69].
Classification was performed as shown in Fig. 4.3. Using prior biological knowl-
edge, 858 genes were selected for investigation with this dataset. To further aid
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838 Genes from prior knowledge
Expression Filtering
Subsets of size 2 and 3
(1.7M)
BEE calculation
Top 1000 gene sets from each 
comparison and gene set size
BEEMSE calculation Delta calculation
Gene sets size = 3
Figure 4.3: Classification of 858 genes from prior knowledge was performed with an
expression filtration step, then BEE calculations were performed on all 1.7M gene sets
across the three comparisons and two dimensionalities (sets of two and three genes).
Then the lowest 1000 classification error sets were selected from each comparison
and run in additional BEEMSE and ∆ calculations.
biological interpretation, we filtered out genes with an FPKM value and average
read count of less than one in both groups of the comparison. Moreover, we only
considered genes where the absolute value of the log fold change between the groups
was greater than 0.3.
This filtering reduced the list of genes to be evaluated from the previously selected
858 to 185, 58, and 159 in the fpa-cpa, cpa-cca, and fpa-cca comparisons, respectively.
Computing all two and three gene subsets of these three comparisons resulted in 1.7M
BEE calculations to be performed over 200 cores over a period of several days.
Subsequently, the top 1000 gene sets from each comparison and dimensionality
(two and three) were additionally used to perform BEEMSE and ∆ computations.
The computations described in Section 4.2.2 require knowledge or an estimate
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Figure 4.4: For the fpa-cca comparison the above histogram for all 12,000 genes and
for the 858 genes in the prior knowledge gene list show that the majority of genes in
the prior knowledge list set are not differentially expressed and have a distribution
of P-values to the entire dataset.
for the value of the parameter c. Because of the specific experimental design and the
purpose of the OBC classification, i.e. to examine sets of genes that can discriminate
well between the experimentally generated phenotypes, we assume c = 0.5. This
choice reflects the experimental design that makes no a priori preference towards
the classes being compared. Thus, we considered the error contribution from each
class as equally important.
4.4 Results
4.4.1 Differential expression analysis
To establish a point of comparison Fig. 4.4 shows the distribution of un-adjusted
P-values for the entire 12,000 genes in the fpa-cca comparison and of the 858 genes
used in classification. The distribution of P-values for the 858 genes shows that most
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Table 4.1: The top ten differentially expressed genes of the 858 gene list by adjusted
P-value as reported by DESeq in the fpa-cca comparison.
Gene Adjusted P-Value
Hoxa2 0.0001
Fabp1 0.0061
Nucks1 0.0085
Plaa 0.0227
P4hb 0.0227
Il6st 0.0250
Pax6 0.0517
Aldh2 0.0774
Ccndbp1 0.0784
Rxra 0.0867
genes were not differentially expressed and the distribution of P-values was similar
to that of the entire dataset.
Table 4.1 shows the top 10 genes from the 858 gene list as reported by adjusted
P-value from DESeq. Using a traditional 0.05 threshold, only six genes would be
considered statistically differentially expressed.
4.4.2 Overall error distributions
The overall distributions of classification errors from a random sampling of the
300M possible gene sets from the 858 prior-knowledge-selected genes are given in
Fig. 4.5 split across the number of genes used and the phenotype comparison.
Classification errors in the cpa-cca comparison are significantly higher than the
other two groups. This matches previous qPCR data (not published) that also in-
dicated greater transcriptional differences in animals fed dietary fat as opposed to
fiber. It can also be noted that the three-gene sets show slightly lower classification
errors on average than the two-gene sets.
Fig. 4.6 shows the relationship between the BEE and the BEEMSE across this
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Figure 4.5: The overall classification error distributions are shown by the number of
features (panel x-axis), dietary comparison (panel y-axis), and normalization type
(stacked plot colors). Average classification error is slightly lower (0.28 vs 0.30) as
expected for classification with 3 genes when compared against two genes. Addition-
ally, the three dietary comparisons (oil and fiber types (FP/CC), oil only (FP/CP),
and fiber only (CP/CC)), showed differences in average classification performance.
dataset. The figure shows that the BEE and BEEMSE are tightly correlated at low
BEE values, and this correlation diminishes at higher values of the BEE.
More gene sets in the lower left of Fig. 4.6 indicates that the fpa-cca and fpa-
cpa comparisons are well separated by a larger combination of genes than the cpa-
cca comparison. The fewer number of gene sets in the lower left for the cpa-cca
comparison indicates that the transcriptional differences between the phenotypes are
small, we are considering the wrong set of genes, or the data for these phenotypes
might contain a higher level of noise.
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Figure 4.6: For the best 1000 gene sets for each dietary comparison, the BEEMSE
tends to increase as a function of BEE.
As more genes are used for classification, the points shift to the left and down as
the dataset becomes more separable (if any such separation exists).
The top four gene pairs from each classification grouping are shown in Table 4.2.
Genes such as Fabp1 are present both in this list for classification and in Table 4.1 as
a differentially expressed gene for the fpa-cca comparison. Most other genes, however,
have non-significant adjusted P-values, such as Arg2 (P=0.11, adjusted P=1.0) and
Adamts1 (P=0.82, adjusted P=1.0), yet together can have classification errors of less
than 1%. This is illustrated along with the OBC decision boundary in Fig. 4.7.
For classifications using gene sets of size three, we compute ∆ to show the amount
of classification improvement by adding an additional gene. Fig. 4.8 shows the dis-
tribution of ∆ for the three comparison groups. Because the cpa-cca comparison
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Figure 4.7: Normalized count expressions are shown for the three genes Arg2,
Lgals3bp, and Adamts1. The cubes and spheres indicate the fpa and cca sam-
ples, respectively. Using the marching cubes contouring algorithm, an approximate
rendering of the nonlinear OBC decision boundary is also displayed.
has the highest classification errors it shows the largest improvements (> 0.02) by
adding an additional feature to the classification problem.
One concern with using approximation algorithms is whether the computation is
sufficiently repeatable. To address this, we ran the top 200 gene subsets from each
comparison twice and computed the correlation of BEE estimates from the two runs.
A Pearson correlation coefficient of 0.999 across the six comparisons indicated that
the computation is repeatable.
Fig. 4.9 shows the comparison between no normalization, count-based normal-
ization, and model-based normalization. The normalized counts show an increase in
classification error, potentially due to the 2% rounding error induced from the final
integer conversion.
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Figure 4.8: The distribution of ∆ for the top 1000 gene sets of the three comparison
groups. CPA-CCA has the largest ∆ values which corresponds to that comparison
having the largest classification errors. Negative values of ∆ are due to approximation
error.
4.4.3 Biological findings
The interactions of dietary fiber-derived compounds in the colonic lumen can
have a substantial impact on the metabolism and kinetics of the colon epithelial cell
population and suppress inflammation and neoplasia [12, 59]. It has been proposed
by us and others that n-3 PUFA found in fish oil and butyrate (a fiber fermentation
product) interact in the colon to profoundly suppress colon cancer [23, 10].
We found that in the chemoprotective treatment containing fish oil and fer-
mentable fiber (FPA-CCA), two genes, Fabp1 and Eno3, were prominently detected
together with a wide variety of other genes in the gene sets of length three. The cal-
culated 23 fold over-expression of Fabp1 correlates with previous findings classifying
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Figure 4.9: Overall classification error varied depending on whether normalization
was used (None) and whether it was implemented as a pre-processing step applied
to the data (Counts) or input into the model through the sequencing depth variable
d (Model).
Fabp1 as a tumor suppressor in colon cancer [62, 80]. Since Fabp1 is a gene involved
in the uptake and metabolic processing of PUFA, the higher levels of fish oil derived
n-3 PUFA are the most likely cause for its increased expression and chemoprotec-
tive activity [73]. The 1.3 fold upregulation of Eno3 is likely due to the fermentable
fiber in the diet. Fermentable fiber leads to the generation of the HDAC inhibitor
butyrate, which has been previously associated with concurrent increases in enolase
3 (Eno3) levels and differentiation, a hallmark of chemoprotection [85, 87]. The
expression levels of Fabp1 and Eno3 are shown along with the OBC classification
boundary in Fig. 4.10.
Other genes present with Fabp1 and Eno3 included Ccnd2 (BEE=0.018), Arg2
(BEE=0.004) and Cdk1 (BEE=0.014). Ccnd2, a gene responsible for enhancing can-
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Figure 4.10: Normalized counts of the Fabp1 and Eno3 genes were plotted against
each other in relation to the OBC decision boundary (black line) for the fpa-cca
comparison.
cer cell proliferation, was downregulated by 1.4 fold in the FPA chemoprotective diet.
Similarly, anti-oncogenic genes Arg2 and Cdk1 were also present in low-classification
gene sets of size three and these were elevated by 3.34 fold and 1.28 fold, respec-
tively, in the FPA diet. Both of these genes can be upregulated by HDAC inhibitors,
a putative mechanism for the chemoprotective nature of these diets [64, 74].
Although these three genes were not considered differentially expressed through
individual testing (P-values of 0.11, 0.36, and 0.51 for Arg2, Ccnd2, and Cdk1,
respectively), they were indicated as highly predictive in delineating the phenotype
when using the Bayesian error estimator. These data suggest that via multivariate
interactions with other genes, the BEE highlights novel genes for the purposes of
hypothesis generation or further biomarker development/validation. This supports
the biological relevance of the BEE as a useful tool in RNA-seq analysis.
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4.5 Conclusion
This work demonstrates an application of the OBC and BEE in identifying multi-
variate gene interactions in RNA-Seq data for the purpose of differentiating biological
phenotypes.
Using 858 genes selected by prior knowledge in a preclinical RNA-Seq dataset, we
identified genes that in combination yield low classification errors, whereas each gene
individually had a large P-value for differential expression. Thus, the application of
our previously developed Bayesian classification framework [57] enables investigators
to generate new hypotheses regarding multivariate effects between these gene sets
and the observed phenotypes.
In addition, new tools such as BEE-BEEMSE scatter plots offer additional diag-
nostic visualizations to assess the quality of RNA-Seq data, similarly to a volcano
plots, as done in DE testing. Future work needs to be performed on synthetic data
sets to better uncover the utility of such a graphical representation of the classifi-
cation performance. Computing and reporting the classification improvements as
represented by the ∆ quantity is also of particular interest to biologists as large val-
ues could potentially indicate more complex interactions between genes than merely
P-values or even BEE alone can.
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5. CONCLUSIONS
In this dissertation we laid out two main approaches to utilize prior biological
knowledge for the purposes of predictive inference. This progression represents no-
table advances in computational biology from the data driven methodologies that
prevail in the field to those that utilize both data and other sources of knowledge
about the biology and measurement methodologies.
The algorithm presented to transform incomplete and potentially conflicting bio-
logical pathway knowledge into a stochastic, predictive framework provides a founda-
tion upon which researchers can build or enrich network models. This compliments
the data-driven network inference approaches which are common in the network
inference literature. In addition, the qualitative validation used provides another
technique of testing predictive models utilizing existing literature sources.
Furthermore, we introduced a statistical model for sequencing data, that together
with extension and computational approaches to the Bayesian framework of optimal
minimum mean square error estimation, allowed us to produce the Optimal Bayesian
Classifier for sequencing datasets. This classifier provides a step forward in the field
of biological data classification, and is available in a well documented, open source
code repository (https://github.com/binarybana/OBC.jl). Moreover, it provides
a flexible framework for additional improvements to the model, a platform to test
additional methods of prior construction from biological data, and an example of the
enabling role of computation in directly unlocking optimal estimators with respect
to informative statistical models.
We are currently extending this approach to network models and working to
addressing several important questions.
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• Given an underlying statistical model, which forms of prior information over
the model parameters are most informative towards reducing the uncertainty
of the different estimators of interest?
• Given a model class, is there an optimal complexity for a given data set or
characteristic function?
• For other cost functions (other than mean square error), is the posterior dis-
tribution of the model parameters sufficient to derive the optimal estimator?
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APPENDIX A
ADDITIONAL ALGORITHMS FOR OPTIMAL BAYESIAN CLASSIFICATION
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Algorithm 2: Calibrate Priors - This is the procedure to use discarded fea-
tures to create calibrated prior distributions for use in a classification problem.
Reproduced with permission from [57].
[1] µ-list ← [] Σi,i-list ← [] Σi,j-list ← [] for i = 1 : s do
s pairs sampled Randomly select a pair of features f1, f2 dsub ← data for this
pair Initialize uniform priors MCMCSamples ← N MCMC Samples using
dsub E[µ1],E[µ2]← Sample µ means from MCMCSamples Append
E[µ1],E[µ2] to µ-list Append E[Σ1,1],E[Σ2,2] to Σi,i-list Append E[Σ0,1] to
Σi,j-list sigdiagmean ← mean(Σi,i-list) sigoffmean ← mean(Σi,j-list) sigdiagvar
← 1
s−1
∑s
i=1(sigdiagmean−Σi,i-list[i])2 m̂← mean(µ-list) ν̂ ← var(µ-list)
σ̂2 ← 2× sigdiagmean ×( sigdiagmean2sigdiagvar + 1) ρ̂← sigoffmeansigdiagmean
κ̂← 2×sigdiagmean2siagdiagvar +D + 3
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Algorithm 3: Generate IC Synthetic Data - To examine the effects of indepen-
dent covariance matrices, we used the following IC method to first draw random
covariance matrices for each class, and then to sample data. Reproduced with
permission from [57].
[1] N, dlow, dhigh N : Number of samples desired D ← 20 κ← D + 2 for each
class do
µ← Normal(0, 0.2)× ones(D) σ ← Normal(0, 0.2)
Σ← Inverse-Wishart(ID(κ−D − 1) ∗ σ,D + 2) if Low correlation features
then
off-diagonal(Σ)← 0 data ← empty N ×D matrix lams ← Draw N vectors
from Normal(µ,Σ) for i = 1 : N do
j = 1 : D data[i, j]← Poisson-draw(Uniform(dlow, dhigh)× exp(lams[i, j]))
Algorithm 4: Synthetic Validation Procedure - The steps used to generate the
sets of points for each Ntrn (the number of training samples in each class along
the x-axis in Figure 3.3. Reproduced with permission from [57].
[1] for i = 1 : N do
N : Number of averages desired µ0 ← Normal-draw(0.0, 0.2)
µ1 ← Normal-draw(0.0, 0.2) σ0 ← InverseGamma-draw(3.0, 1.0)
σ1 ← InverseGamma-draw(3.0, 1.0) train-data-0 ← genData(µ0, σ1, Ntrn, ρ)
train-data-1 ← genData(µ1, σ1, Ntrn, ρ) test-data-0 ← genData(µ0, σ1, Ntest, ρ)
test-data-1 ← genData(µ0, σ1, Ntest, ρ) used-features ← Randomly select 4
features Using Training data: hyperparameters ← MCMC using Algorithm 1
and used-featuresc Train (Run) Calibrated MCMC with hyperparameters
Train (Run) MCMC with weakly informative priors Train SVM Train LDA
Train 3NN Train Normal OBC Using testing data: Evaluate Calibrated
MCMC Evaluate MCMC with weakly informative priors Evaluate SVM
Evaluate LDA Evaluate 3NN Evaluate Normal OBC
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Algorithm 5: Real Data Validation Procedure - The procedure used to gen-
erate each set of points along the x-axis of Figure 3.4 given a desired number
of training samples Ntrntotal over N averages with an a priori known value of c.
Reproduced with permission from [57].
[1] for i = 1 : N do
N : Number of averages desired train-data0 ← draw round(c ∗Ntrntotal) samples
from data0 train-data1 ← draw round((1− c) ∗Ntrntotal) samples from data1
test-data0 ← data0 - train-data0 test-data1 ← data1 - train-data1 used-features
← Randomly select 4 features Using Training data: hyperparameters ←
Algorithm 1 MCMC using used-featuresc Train (Run) Calibrated MCMC
using hyperparameters Train (Run) MCMC with weakly informative priors
Train SVM Train LDA Train 3NN Train Normal OBC Using testing data:
Evaluate Calibrated MCMC Evaluate MCMC with weakly informative priors
Evaluate SVM Evaluate LDA Evaluate 3NN Evaluate Normal OBC
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APPENDIX B
ADDITIONAL FIGURES FOR OPTIMAL BAYESIAN CLASSIFICATION
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Figure B.1: The multivariate normal distribution used to generate samples for the
IC synthetic data case. The block structure indicates the several different types of
features that are generated. Used with permission from Ghaffari et al., 2013 [36].
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Figure B.2: A simple two class, two gene, synthetic example demonstrates the use of
the MP OBC. Six training samples from each class (circles and triangles) are shown
in all four panels and used to train the MP model. After MCMC computation,
the resulting effective class conditional density contour is shown for the triangles
in panel a and the circles in panel b. Panel c then shows the resulting MP OBC
decision boundary resulting from these effective class conditional densities and panel
d shows the contours of the optimal Bayes conditional error estimate plotted next to
the classifier decision boundary. Reproduced with permission from [57].
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Figure B.3: Using the same classifier, we can now evaluate the performance of the
classifier using 3000 testing samples from each class. When evaluated and averaged,
this particular example results in a classification error of 0.29. Reproduced with
permission from [57].
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Figure B.4: Two examples of 100 samples from adenocarcinoma TCGA tumor sam-
ples and the posterior predictive xrep simulation from the MP model. Reproduced
with permission from [57].
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APPENDIX C
ADDITIONAL BAYESIAN POSTERIOR P-VALUES
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Table C.1: Posterior predictive model diagnostic – 5th quantile. Reproduced with
permission from [57].
Gene ID Mean expression (counts) T (Sn) 95th int. T (xrep) P-value
MRGPRX1|259249 0.0 0.00 [0.00, 0.00] 0.50
C17orf105|284067 0.0 0.00 [0.00, 0.00] 0.50
HBBP1|3044 0.1 0.00 [0.00, 0.00] 0.50
SNORA18|677805 0.2 0.00 [0.00, 0.00] 0.50
SCN10A|6336 0.3 0.00 [0.00, 0.00] 0.50
CDCP2|200008 0.7 0.00 [0.00, 0.00] 0.50
FGF17|8822 3.3 0.00 [0.00, 0.00] 0.50
NTN5|126147 5.7 1.32 [0.00, 0.00] 0.00
NCRNA00185|55410 11.5 0.00 [0.00, 0.00] 0.50
CCR8|1237 16.6 1.46 [0.00, 1.90] 0.06
CCDC33|80125 23.1 0.00 [0.00, 0.00] 0.50
PPAPDC3|84814 23.5 6.00 [2.95, 8.95] 0.32
PCDHGB2|56103 68.1 5.19 [1.95, 10.80] 0.47
FAM81A|145773 81.1 13.38 [5.00, 17.90] 0.23
ZNF383|163087 81.2 54.44 [24.00, 48.45] 0.01
ANKRD1|27063 87.1 1.23 [0.00, 3.95] 0.52
UGT2B4|7363 93.4 0.00 [0.00, 0.00] 0.50
IL12RB1|3594 98.9 15.33 [13.85, 36.40] 0.88
ZNF628|89887 160.0 75.54 [41.95, 83.80] 0.16
FBF1|85302 184.2 52.03 [29.60, 75.50] 0.41
ZNF615|284370 209.2 70.60 [36.95, 81.40] 0.16
RHBDD1|84236 299.9 127.69 [82.90, 170.90] 0.46
NICN1|84276 330.1 173.29 [87.95, 187.40] 0.12
COQ6|51004 369.7 193.25 [106.95, 194.20] 0.05
CHAF1A|10036 387.3 150.70 [81.55, 190.65] 0.30
DTD1|92675 534.5 273.70 [141.50, 282.20] 0.07
EARS2|124454 663.7 380.07 [193.10, 356.85] 0.03
KIAA1737|85457 668.3 365.58 [214.25, 393.95] 0.12
LRRC8D|55144 690.2 445.36 [214.45, 405.95] 0.02
SKIL|6498 691.0 336.66 [199.70, 368.85] 0.15
WDR36|134430 761.6 531.67 [258.20, 479.55] 0.02
ZNF259|8882 831.0 455.39 [221.15, 425.20] 0.03
CHSY1|22856 1029.7 474.64 [269.05, 548.10] 0.15
DHX8|1659 1192.9 695.25 [354.10, 728.70] 0.08
AGTRAP|57085 1254.0 539.55 [283.75, 622.85] 0.20
VPS26B|112936 1337.3 643.79 [350.35, 716.25] 0.17
MCM4|4173 1543.3 343.29 [202.80, 528.50] 0.51
SLC2A3|6515 1559.7 338.07 [178.00, 474.20] 0.38
VPS39|23339 1594.0 908.35 [460.90, 964.45] 0.07
FOXA1|3169 1800.3 396.41 [217.10, 584.20] 0.40
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Table C.2: Posterior predictive model diagnostic – Median. Reproduced with per-
mission from [57].
Gene ID Mean expression (counts) T (Sn) 95th int. T (xrep) P-value
MRGPRX1|259249 0.0 0.00 [0.00, 0.00] 0.50
C17orf105|284067 0.0 0.00 [0.00, 0.00] 0.50
HBBP1|3044 0.1 0.00 [0.00, 0.00] 0.50
SNORA18|677805 0.2 0.00 [0.00, 0.00] 0.50
SCN10A|6336 0.3 0.00 [0.00, 0.00] 0.50
CDCP2|200008 0.7 0.00 [0.00, 0.00] 0.50
FGF17|8822 3.3 1.01 [0.00, 1.00] 0.03
NTN5|126147 5.7 4.35 [2.00, 7.50] 0.41
NCRNA00185|55410 11.5 0.00 [0.00, 0.00] 0.50
CCR8|1237 16.6 12.18 [4.00, 17.50] 0.22
CCDC33|80125 23.1 6.01 [1.00, 10.00] 0.17
PPAPDC3|84814 23.5 19.68 [13.50, 24.00] 0.36
PCDHGB2|56103 68.1 33.59 [18.50, 46.00] 0.34
FAM81A|145773 81.1 45.82 [31.00, 71.50] 0.59
ZNF383|163087 81.2 85.50 [68.00, 104.50] 0.45
ANKRD1|27063 87.1 20.69 [9.50, 34.00] 0.36
UGT2B4|7363 93.4 1.77 [0.00, 4.00] 0.30
IL12RB1|3594 98.9 80.38 [56.50, 110.00] 0.45
ZNF628|89887 160.0 158.95 [121.00, 194.50] 0.39
FBF1|85302 184.2 162.49 [111.00, 211.00] 0.28
ZNF615|284370 209.2 184.09 [126.00, 218.00] 0.25
RHBDD1|84236 299.9 275.19 [214.00, 337.50] 0.48
NICN1|84276 330.1 320.44 [264.00, 436.00] 0.60
COQ6|51004 369.7 335.85 [265.00, 405.00] 0.46
CHAF1A|10036 387.3 302.09 [252.50, 452.50] 0.75
DTD1|92675 534.5 523.20 [385.00, 626.00] 0.30
EARS2|124454 663.7 603.62 [485.00, 732.50] 0.41
KIAA1737|85457 668.3 676.88 [529.00, 806.50] 0.39
LRRC8D|55144 690.2 645.04 [550.50, 835.00] 0.67
SKIL|6498 691.0 594.36 [479.50, 761.00] 0.56
WDR36|134430 761.6 752.27 [631.50, 909.00] 0.55
ZNF259|8882 831.0 658.89 [551.00, 903.00] 0.71
CHSY1|22856 1029.7 872.60 [721.00, 1146.50] 0.59
DHX8|1659 1192.9 1150.34 [957.00, 1552.00] 0.67
AGTRAP|57085 1254.0 1069.75 [839.00, 1375.50] 0.55
VPS26B|112936 1337.3 1189.98 [912.00, 1415.00] 0.40
MCM4|4173 1543.3 1094.04 [795.00, 1417.00] 0.41
SLC2A3|6515 1559.7 1053.06 [719.50, 1420.50] 0.45
VPS39|23339 1594.0 1651.32 [1274.00, 2078.50] 0.43
FOXA1|3169 1800.3 1168.83 [887.50, 1642.00] 0.62
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Table C.3: Posterior predictive model diagnostic – 95th quantile. Reproduced with
permission from [57].
Gene ID Mean expression (counts) T (Sn) 95th int. T (xrep) P-value
MRGPRX1|259249 0.0 0.00 [0.00, 0.00] 0.50
C17orf105|284067 0.0 1.01 [0.00, 0.05] 0.00
HBBP1|3044 0.1 0.50 [0.00, 1.00] 0.07
SNORA18|677805 0.2 0.25 [0.00, 0.00] 0.00
SCN10A|6336 0.3 1.49 [0.05, 7.45] 0.38
CDCP2|200008 0.7 2.12 [0.05, 25.10] 0.56
FGF17|8822 3.3 16.60 [6.35, 279.40] 0.78
NTN5|126147 5.7 14.10 [16.40, 109.85] 0.97
NCRNA00185|55410 11.5 38.88 [1.05, 146.00] 0.20
CCR8|1237 16.6 38.64 [42.30, 308.40] 0.97
CCDC33|80125 23.1 107.94 [59.25, 2444.60] 0.85
PPAPDC3|84814 23.5 48.09 [35.05, 87.75] 0.66
PCDHGB2|56103 68.1 179.96 [89.40, 276.50] 0.36
FAM81A|145773 81.1 200.17 [127.60, 378.45] 0.54
ZNF383|163087 81.2 144.50 [144.55, 263.35] 0.95
ANKRD1|27063 87.1 225.79 [82.90, 400.90] 0.31
UGT2B4|7363 93.4 54.66 [19.50, 1361.35] 0.80
IL12RB1|3594 98.9 230.41 [155.80, 432.00] 0.65
ZNF628|89887 160.0 299.84 [269.00, 554.20] 0.86
FBF1|85302 184.2 374.78 [297.80, 748.75] 0.72
ZNF615|284370 209.2 368.14 [316.55, 769.65] 0.87
RHBDD1|84236 299.9 427.40 [455.05, 820.10] 0.97
NICN1|84276 330.1 737.03 [611.90, 1253.15] 0.74
COQ6|51004 369.7 568.48 [542.15, 1066.55] 0.90
CHAF1A|10036 387.3 834.67 [617.75, 1323.90] 0.54
DTD1|92675 534.5 989.05 [832.60, 1590.50] 0.75
EARS2|124454 663.7 1005.24 [970.90, 1902.00] 0.91
KIAA1737|85457 668.3 887.21 [1075.65, 1961.85] 1.00
LRRC8D|55144 690.2 1086.87 [1088.05, 2025.85] 0.95
SKIL|6498 691.0 1140.47 [1019.95, 2039.50] 0.80
WDR36|134430 761.6 1220.71 [1231.45, 2132.60] 0.95
ZNF259|8882 831.0 1169.19 [1186.25, 2164.80] 0.95
CHSY1|22856 1029.7 1705.17 [1557.95, 2971.50] 0.86
DHX8|1659 1192.9 1953.12 [2051.05, 4246.15] 0.97
AGTRAP|57085 1254.0 2240.63 [1841.20, 4096.95] 0.76
VPS26B|112936 1337.3 1847.39 [1949.45, 3436.10] 0.97
MCM4|4173 1543.3 3410.08 [2205.70, 5370.80] 0.41
SLC2A3|6515 1559.7 3378.11 [2183.05, 5712.85] 0.51
VPS39|23339 1594.0 2514.10 [2719.90, 5625.80] 0.98
FOXA1|3169 1800.3 3302.97 [2553.55, 6376.40] 0.73
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Table C.4: Posterior predictive model diagnostic – IQR. Reproduced with permission
from [57].
Gene ID Mean expression (counts) T (Sn) 95th int. T (xrep) P-value
MRGPRX1|259249 0.0 0.00 [0.00, 0.00] 0.50
C17orf105|284067 0.0 0.00 [0.00, 0.00] 0.50
HBBP1|3044 0.1 0.00 [0.00, 0.00] 0.50
SNORA18|677805 0.2 0.00 [0.00, 0.00] 0.50
SCN10A|6336 0.3 0.50 [0.00, 0.00] 0.03
CDCP2|200008 0.7 0.98 [0.00, 1.00] 0.07
FGF17|8822 3.3 2.59 [1.00, 9.00] 0.52
NTN5|126147 5.7 6.93 [4.50, 21.75] 0.75
NCRNA00185|55410 11.5 5.45 [0.00, 1.50] 0.00
CCR8|1237 16.6 17.69 [11.00, 58.00] 0.66
CCDC33|80125 23.1 17.19 [6.25, 93.25] 0.60
PPAPDC3|84814 23.5 13.91 [11.00, 25.50] 0.79
PCDHGB2|56103 68.1 43.70 [28.50, 82.25] 0.60
FAM81A|145773 81.1 63.53 [38.75, 109.75] 0.51
ZNF383|163087 81.2 34.43 [40.25, 86.75] 1.00
ANKRD1|27063 87.1 74.52 [21.25, 83.75] 0.11
UGT2B4|7363 93.4 6.98 [2.00, 43.50] 0.64
IL12RB1|3594 98.9 84.17 [47.50, 130.00] 0.42
ZNF628|89887 160.0 100.43 [78.50, 171.50] 0.73
FBF1|85302 184.2 154.54 [95.00, 226.75] 0.36
ZNF615|284370 209.2 117.16 [96.00, 228.50] 0.82
RHBDD1|84236 299.9 126.20 [128.75, 275.50] 0.96
NICN1|84276 330.1 246.20 [179.75, 411.50] 0.61
COQ6|51004 369.7 153.72 [153.50, 361.00] 0.95
CHAF1A|10036 387.3 234.48 [172.75, 422.25] 0.72
DTD1|92675 534.5 297.30 [236.75, 533.75] 0.77
EARS2|124454 663.7 237.65 [262.25, 578.50] 0.98
KIAA1737|85457 668.3 220.32 [281.50, 651.75] 0.99
LRRC8D|55144 690.2 359.07 [285.00, 655.50] 0.83
SKIL|6498 691.0 247.07 [290.75, 615.75] 1.00
WDR36|134430 761.6 216.40 [331.25, 737.50] 1.00
ZNF259|8882 831.0 322.44 [314.50, 715.00] 0.94
CHSY1|22856 1029.7 441.38 [442.25, 1005.00] 0.95
DHX8|1659 1192.9 582.12 [584.75, 1240.00] 0.95
AGTRAP|57085 1254.0 622.58 [532.25, 1264.50] 0.86
VPS26B|112936 1337.3 529.40 [536.00, 1111.25] 0.96
MCM4|4173 1543.3 835.39 [631.25, 1588.50] 0.74
SLC2A3|6515 1559.7 845.02 [611.00, 1788.75] 0.79
VPS39|23339 1594.0 586.40 [764.75, 1831.00] 1.00
FOXA1|3169 1800.3 1275.06 [765.00, 2040.75] 0.50
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Table C.5: Posterior predictive model diagnostic – Variance. Reproduced with per-
mission from [57].
Gene ID Mean expression
(counts)
T (Sn) 95th int. T (xrep) P-value
MRGPRX1|259249 0.0 0.00 [0.00, 0.00] 0.04
C17orf105|284067 0.0 0.11 [0.00, 0.12] 0.07
HBBP1|3044 0.1 0.08 [0.00, 0.25] 0.13
SNORA18|677805 0.2 0.01 [0.00, 0.05] 0.25
SCN10A|6336 0.3 0.36 [0.05, 1242.64] 0.69
CDCP2|200008 0.7 0.74 [0.16, 5117.85] 0.80
FGF17|8822 3.3 26.34 [32.90, 1109445.84] 0.97
NTN5|126147 5.7 42.93 [51.13, 8446.14] 0.96
NCRNA00185|55410 11.5 303.63 [1.35, 1340191.71] 0.53
CCR8|1237 16.6 157.20 [285.39, 81521.57] 0.98
CCDC33|80125 23.1 14201.11 [2292.16, 31223489.92] 0.79
PPAPDC3|84814 23.5 181.37 [112.92, 1048.31] 0.80
PCDHGB2|56103 68.1 4048.26 [1228.20, 20426.96] 0.52
FAM81A|145773 81.1 5661.96 [1970.14, 26450.20] 0.53
ZNF383|163087 81.2 1206.74 [1301.43, 6287.70] 0.96
ANKRD1|27063 87.1 9884.12 [1356.27, 51853.87] 0.36
UGT2B4|7363 93.4 5664.11 [291.72, 8368761.19] 0.66
IL12RB1|3594 98.9 4745.05 [2290.87, 27420.28] 0.79
ZNF628|89887 160.0 6534.92 [5024.43, 31689.22] 0.87
FBF1|85302 184.2 12711.43 [7286.06, 71120.08] 0.77
ZNF615|284370 209.2 11122.81 [9659.19, 69434.34] 0.88
RHBDD1|84236 299.9 8546.28 [13399.90, 63578.81] 0.99
NICN1|84276 330.1 32463.87 [26378.50, 154304.78] 0.87
COQ6|51004 369.7 15005.15 [19147.05, 94982.52] 0.98
CHAF1A|10036 387.3 47233.01 [28450.33, 196129.54] 0.74
DTD1|92675 534.5 59301.87 [45681.73, 251258.48] 0.90
EARS2|124454 663.7 52839.46 [58542.64, 301221.33] 0.98
KIAA1737|85457 668.3 48505.67 [75259.02, 340071.74] 0.99
LRRC8D|55144 690.2 48918.16 [78779.94, 378872.68] 1.00
SKIL|6498 691.0 56797.55 [69545.32, 366715.84] 0.97
WDR36|134430 761.6 49947.90 [88525.22, 422834.77] 1.00
ZNF259|8882 831.0 88575.80 [82583.27, 472063.68] 0.94
CHSY1|22856 1029.7 201986.35 [168564.65, 873474.11] 0.90
DHX8|1659 1192.9 348984.33 [285590.39, 1578955.67] 0.87
AGTRAP|57085 1254.0 424287.54 [248618.71, 1869240.10] 0.71
VPS26B|112936 1337.3 158070.60 [240558.63, 1169889.12] 1.00
MCM4|4173 1543.3 901681.93 [386142.75, 3614045.91] 0.63
SLC2A3|6515 1559.7 1037093.04 [421036.96, 4698669.95] 0.61
VPS39|23339 1594.0 328769.35 [481155.30, 2674633.59] 1.00
FOXA1|3169 1800.3 1688527.66 [680898.40, 7470155.18] 0.54
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